Κ ΑΡΧΕΙΟΥ Α Κ ΕΟΦ ΟΝΟΜΑΣΙΑ Κ ΕΤ ΠΕΡΙΓΡΑΦΗ … · 62 57322...

46
Α/Α ΚΩΔ. ΑΡΧΕΙΟΥ ΓΓΕ ΚΩΔ. ΕΟΦ ΟΝΟΜΑΣΙΑ ΚΩΔ. ΕΤ. ΠΕΡΙΓΡΑΦΗ ΕΤΑΙΡΕΙΑΣ Ν.3816 ΧΟΝΔΡΙΚΗ ΝΟΣΟΚΟΜΕΙΑΚΗ Ν.ΧΟΝΔΡΙΚΗ ΛΙΑΝΙΚΗ 1 57119 285951101 ABSEAMED INJ.SO.PFS 20.000 IU/0,5ML PF SYR BTx1PFS 662 MEDICE ARZNEIMITTEL GMBH N 112,13 97,55 99,99 125,66 2 57120 285951102 ABSEAMED INJ.SO.PFS 20.000 IU/0,5ML PF SYR BTx6PFS 662 MEDICE ARZNEIMITTEL GMBH N 672,74 585,28 599,91 753,91 3 57121 285951201 ABSEAMED INJ.SO.PFS 30.000 IU/0,5ML PF SYR BTx1PFS 662 MEDICE ARZNEIMITTEL GMBH N 168,18 146,32 149,98 188,48 4 57122 285951202 ABSEAMED INJ.SO.PFS 30.000 IU/0,5ML PF SYR BTx6PFS 662 MEDICE ARZNEIMITTEL GMBH N 1009,08 877,90 899,85 1130,84 5 57123 285951301 ABSEAMED INJ.SO.PFS 40.000 IU/1,0ML PF SYR BTx1PFS 662 MEDICE ARZNEIMITTEL GMBH N 224,23 195,08 199,96 251,29 6 57124 285951302 ABSEAMED INJ.SO.PFS 40.000 IU/1,0ML PF SYR BTx6PFS 662 MEDICE ARZNEIMITTEL GMBH N 1345,45 1170,54 1199,80 1507,79 7 56348 285950801 ABSEAMED INJ.SOL.PFS 10000IU/1,0ML BTx1PF.SYR 662 MEDICE ARZNEIMITTEL GMBH N 53,59 46,62 47,79 60,06 8 56349 285950802 ABSEAMED INJ.SOL.PFS 10000IU/1,0ML BTx6PF.SYR 662 MEDICE ARZNEIMITTEL GMBH N 336,37 292,64 299,96 376,96 9 56350 285950101 ABSEAMED INJ.SOL.PFS 1000IU/0,5ML BTx1PF.SYR 662 MEDICE ARZNEIMITTEL GMBH N 5,99 5,21 5,34 6,71 10 56351 285950102 ABSEAMED INJ.SOL.PFS 1000IU/0,5ML BTx6PF.SYR 662 MEDICE ARZNEIMITTEL GMBH N 33,26 28,94 29,66 37,27 11 56352 285950201 ABSEAMED INJ.SOL.PFS 2000IU/1,0ML BTx1PF.SYR 662 MEDICE ARZNEIMITTEL GMBH N 11,10 9,66 9,90 12,44 12 56353 285950202 ABSEAMED INJ.SOL.PFS 2000IU/1,0ML BTx6PF.SYR 662 MEDICE ARZNEIMITTEL GMBH N 67,28 58,53 59,99 75,39 13 56354 285950301 ABSEAMED INJ.SOL.PFS 3000IU/0,3ML BTx1PF.SYR 662 MEDICE ARZNEIMITTEL GMBH N 16,67 14,50 14,86 18,67 14 56355 285950302 ABSEAMED INJ.SOL.PFS 3000IU/0,3ML BTx6PF.SYR 662 MEDICE ARZNEIMITTEL GMBH N 100,91 87,79 89,98 113,08 15 56356 285950401 ABSEAMED INJ.SOL.PFS 4000IU/0,4ML BTx1PF.SYR 662 MEDICE ARZNEIMITTEL GMBH N 22,07 19,20 19,68 24,73 Page 1 of 46

Transcript of Κ ΑΡΧΕΙΟΥ Α Κ ΕΟΦ ΟΝΟΜΑΣΙΑ Κ ΕΤ ΠΕΡΙΓΡΑΦΗ … · 62 57322...

Page 1: Κ ΑΡΧΕΙΟΥ Α Κ ΕΟΦ ΟΝΟΜΑΣΙΑ Κ ΕΤ ΠΕΡΙΓΡΑΦΗ … · 62 57322 248400705 aranesp solution for injection 60mcg/0,3ml pf.syr./ btx4pf.syr with needle guard

Α/ΑΚΩ∆. ΑΡΧΕΙΟΥ

ΓΓΕ ΚΩ∆. ΕΟΦ ΟΝΟΜΑΣΙΑ ΚΩ∆. ΕΤ. ΠΕΡΙΓΡΑΦΗ ΕΤΑΙΡΕΙΑΣ Ν.3816 ΧΟΝ∆ΡΙΚΗ ΝΟΣΟΚΟΜΕΙΑΚΗ Ν.ΧΟΝ∆ΡΙΚΗ ΛΙΑΝΙΚΗ

1 57119 285951101ABSEAMED INJ.SO.PFS 20.000 IU/0,5ML PF SYR BTx1PFS

662MEDICE ARZNEIMITTEL GMBH

N 112,13 97,55 99,99 125,66

2 57120 285951102ABSEAMED INJ.SO.PFS 20.000 IU/0,5ML PF SYR BTx6PFS

662MEDICE ARZNEIMITTEL GMBH

N 672,74 585,28 599,91 753,91

3 57121 285951201ABSEAMED INJ.SO.PFS 30.000 IU/0,5ML PF SYR BTx1PFS

662MEDICE ARZNEIMITTEL GMBH

N 168,18 146,32 149,98 188,48

4 57122 285951202ABSEAMED INJ.SO.PFS 30.000 IU/0,5ML PF SYR BTx6PFS

662MEDICE ARZNEIMITTEL GMBH

N 1009,08 877,90 899,85 1130,84

5 57123 285951301ABSEAMED INJ.SO.PFS 40.000 IU/1,0ML PF SYR BTx1PFS

662MEDICE ARZNEIMITTEL GMBH

N 224,23 195,08 199,96 251,29

6 57124 285951302ABSEAMED INJ.SO.PFS 40.000 IU/1,0ML PF SYR BTx6PFS

662MEDICE ARZNEIMITTEL GMBH

N 1345,45 1170,54 1199,80 1507,79

7 56348 285950801ABSEAMED INJ.SOL.PFS 10000IU/1,0ML BTx1PF.SYR

662MEDICE ARZNEIMITTEL GMBH

N 53,59 46,62 47,79 60,06

8 56349 285950802ABSEAMED INJ.SOL.PFS 10000IU/1,0ML BTx6PF.SYR

662MEDICE ARZNEIMITTEL GMBH

N 336,37 292,64 299,96 376,96

9 56350 285950101ABSEAMED INJ.SOL.PFS 1000IU/0,5ML BTx1PF.SYR

662MEDICE ARZNEIMITTEL GMBH

N 5,99 5,21 5,34 6,71

10 56351 285950102ABSEAMED INJ.SOL.PFS 1000IU/0,5ML BTx6PF.SYR

662MEDICE ARZNEIMITTEL GMBH

N 33,26 28,94 29,66 37,27

11 56352 285950201ABSEAMED INJ.SOL.PFS 2000IU/1,0ML BTx1PF.SYR

662MEDICE ARZNEIMITTEL GMBH

N 11,10 9,66 9,90 12,44

12 56353 285950202ABSEAMED INJ.SOL.PFS 2000IU/1,0ML BTx6PF.SYR

662MEDICE ARZNEIMITTEL GMBH

N 67,28 58,53 59,99 75,39

13 56354 285950301ABSEAMED INJ.SOL.PFS 3000IU/0,3ML BTx1PF.SYR

662MEDICE ARZNEIMITTEL GMBH

N 16,67 14,50 14,86 18,67

14 56355 285950302ABSEAMED INJ.SOL.PFS 3000IU/0,3ML BTx6PF.SYR

662MEDICE ARZNEIMITTEL GMBH

N 100,91 87,79 89,98 113,08

15 56356 285950401ABSEAMED INJ.SOL.PFS 4000IU/0,4ML BTx1PF.SYR

662MEDICE ARZNEIMITTEL GMBH

N 22,07 19,20 19,68 24,73

Page 1 of 46

Page 2: Κ ΑΡΧΕΙΟΥ Α Κ ΕΟΦ ΟΝΟΜΑΣΙΑ Κ ΕΤ ΠΕΡΙΓΡΑΦΗ … · 62 57322 248400705 aranesp solution for injection 60mcg/0,3ml pf.syr./ btx4pf.syr with needle guard

Α/ΑΚΩ∆. ΑΡΧΕΙΟΥ

ΓΓΕ ΚΩ∆. ΕΟΦ ΟΝΟΜΑΣΙΑ ΚΩ∆. ΕΤ. ΠΕΡΙΓΡΑΦΗ ΕΤΑΙΡΕΙΑΣ Ν.3816 ΧΟΝ∆ΡΙΚΗ ΝΟΣΟΚΟΜΕΙΑΚΗ Ν.ΧΟΝ∆ΡΙΚΗ ΛΙΑΝΙΚΗ

16 56357 285950402ABSEAMED INJ.SOL.PFS 4000IU/0,4ML BTx6PF.SYR

662MEDICE ARZNEIMITTEL GMBH

N 134,55 117,06 119,99 150,79

17 56358 285950501ABSEAMED INJ.SOL.PFS 5000IU/0,5ML BTx1PF.SYR

662MEDICE ARZNEIMITTEL GMBH

N 27,79 24,18 24,78 31,14

18 56359 285950502ABSEAMED INJ.SOL.PFS 5000IU/0,5ML BTx6PF.SYR

662MEDICE ARZNEIMITTEL GMBH

N 168,20 146,33 149,99 188,49

19 56360 285950601ABSEAMED INJ.SOL.PFS 6000IU/0,6ML BTx1PF.SYR

662MEDICE ARZNEIMITTEL GMBH

N 33,33 29,00 29,73 37,36

20 56361 285950602ABSEAMED INJ.SOL.PFS 6000IU/0,6ML BTx6PF.SYR

662MEDICE ARZNEIMITTEL GMBH

N 201,83 175,59 179,98 226,18

21 56362 285950701ABSEAMED INJ.SOL.PFS 8000IU/0,8ML BTx1PF.SYR

662MEDICE ARZNEIMITTEL GMBH

N 44,46 38,68 39,65 49,83

22 56363 285950702ABSEAMED INJ.SOL.PFS 8000IU/0,8ML BTx6PF.SYR

662MEDICE ARZNEIMITTEL GMBH

N 269,09 234,11 239,96 301,56

23 55759 278140101ADVAGRAF PR. CAP 0,5MG/CAP BTx30 (BLISTERS (PVC/PVDC/ALU)

575 ASTELLAS PHARMA GMBH N 28,46 24,76 25,38 31,90

24 55760 278140201ADVAGRAF PR. CAP 1MG/CAP BTx30 (BLISTERS (PVC/PVDC/ALU)

575 ASTELLAS PHARMA GMBH N 52,82 45,95 47,10 59,19

25 55761 278140301ADVAGRAF PR. CAP 5MG/CAP BTx30 (BLISTERS (PVC/PVDC/ALU)

575 ASTELLAS PHARMA GMBH N 239,10 208,02 213,22 267,95

26 57309 278140401ADVAGRAF, PR.CAP. 3MG/CAP, BT x 30 (3 x 10 BLIST)

440ASTELLAS PHARMACEUTICALS ΑΕΒΕ

N 155,03 134,88 138,25 173,74

27 56646 290970201AFINITOR TAB 10MG/TAB BT x 30 σε BLISTERS (ALU/PA/ALU/PVC)

517NOVARTIS EUROPHARM LTD

N 3579,24 3113,94 3191,79 4011,12

28 56645 290970101AFINITOR TAB 5MG/TAB BT x 30 σε BLISTERS (ALU/PA/ALU/PVC)

517NOVARTIS EUROPHARM LTD

N 2747,13 2390,00 2449,75 3078,60

29 56215 269070101ALDURAZYME CS.SOL.INF 100U/ML BTx1VIAL

465GENZYME BV, NEDERLAND

N 795,00 691,65 708,94 890,92

30 55086 266780101 ALIMTA PD.INF. 1VIALx500MG 566 ELI-LILLY NED B.V. N 1139,85 991,67 1016,46 1277,39

Page 2 of 46

Page 3: Κ ΑΡΧΕΙΟΥ Α Κ ΕΟΦ ΟΝΟΜΑΣΙΑ Κ ΕΤ ΠΕΡΙΓΡΑΦΗ … · 62 57322 248400705 aranesp solution for injection 60mcg/0,3ml pf.syr./ btx4pf.syr with needle guard

Α/ΑΚΩ∆. ΑΡΧΕΙΟΥ

ΓΓΕ ΚΩ∆. ΕΟΦ ΟΝΟΜΑΣΙΑ ΚΩ∆. ΕΤ. ΠΕΡΙΓΡΑΦΗ ΕΤΑΙΡΕΙΑΣ Ν.3816 ΧΟΝ∆ΡΙΚΗ ΝΟΣΟΚΟΜΕΙΑΚΗ Ν.ΧΟΝ∆ΡΙΚΗ ΛΙΑΝΙΚΗ

31 53289 234680201 ANZEMET F.C.TABL 3x200MG 518 SANOFI-AVENTIS AEBE N 29,34 25,53 26,17 32,89

32 53290 234680101 ANZEMET F.C.TABL 3x50MG 518 SANOFI-AVENTIS AEBE N 8,18 7,12 7,30 9,17

33 53292 234680601 ANZEMET INJ SOL BT 1AMPx100MG/5ML 518 SANOFI-AVENTIS AEBE N 16,74 14,56 14,92 18,75

34 54403 248400902 ARANESP INJ 4 PF SYRx100MCG/0,5ML 063 ΓΕΝΕΣΙΣ ΦΑΡΜΑ ΑΕ N 617,52 537,24 550,67 692,03

35 54404 248400102 ARANESP INJ 4 PF SYRx10MCG/0,4ML 063 ΓΕΝΕΣΙΣ ΦΑΡΜΑ ΑΕ N 66,30 57,68 59,12 74,30

36 54405 248401002 ARANESP INJ 4 PF SYRx150MCG/0,3ML 063 ΓΕΝΕΣΙΣ ΦΑΡΜΑ ΑΕ N 950,43 826,87 847,54 1065,10

37 54406 248400202 ARANESP INJ 4 PF SYRx15MCG/0,375ML 063 ΓΕΝΕΣΙΣ ΦΑΡΜΑ ΑΕ N 92,38 80,37 82,38 103,53

38 54407 248400302 ARANESP INJ 4 PF SYRx20MCG/0,5ML 063 ΓΕΝΕΣΙΣ ΦΑΡΜΑ ΑΕ N 127,69 111,09 113,87 143,10

39 54408 248400402 ARANESP INJ 4 PF SYRx30MCG/0,3ML 063 ΓΕΝΕΣΙΣ ΦΑΡΜΑ ΑΕ N 194,89 169,55 173,79 218,40

40 54409 248400502 ARANESP INJ 4 PF SYRx40MCG/0,4ML 063 ΓΕΝΕΣΙΣ ΦΑΡΜΑ ΑΕ N 246,34 214,32 219,68 276,07

41 54410 248400602 ARANESP INJ 4 PF SYRx50MCG/0,5ML 063 ΓΕΝΕΣΙΣ ΦΑΡΜΑ ΑΕ N 307,94 267,91 274,61 345,10

42 54411 248400702 ARANESP INJ 4 PF SYRx60MCG/0,3ML 063 ΓΕΝΕΣΙΣ ΦΑΡΜΑ ΑΕ N 380,74 331,24 339,52 426,67

43 54412 248400802 ARANESP INJ 4 PF SYRx80MCG/0,4ML 063 ΓΕΝΕΣΙΣ ΦΑΡΜΑ ΑΕ N 511,43 444,94 456,06 573,13

44 54968 248401601 ARANESP INJ.SOL 1PF.SYRx500MCG/1ML 063 ΓΕΝΕΣΙΣ ΦΑΡΜΑ ΑΕ N 775,03 674,28 691,14 868,56

45 55150 248402501ARANESP INJ.SOL. 100MCG/0,5ML PF.PEN BTx1PF.PENx0,5ML (SURE CLICK)

063 ΓΕΝΕΣΙΣ ΦΑΡΜΑ ΑΕ N 178,52 155,31 159,19 200,05

Page 3 of 46

Page 4: Κ ΑΡΧΕΙΟΥ Α Κ ΕΟΦ ΟΝΟΜΑΣΙΑ Κ ΕΤ ΠΕΡΙΓΡΑΦΗ … · 62 57322 248400705 aranesp solution for injection 60mcg/0,3ml pf.syr./ btx4pf.syr with needle guard

Α/ΑΚΩ∆. ΑΡΧΕΙΟΥ

ΓΓΕ ΚΩ∆. ΕΟΦ ΟΝΟΜΑΣΙΑ ΚΩ∆. ΕΤ. ΠΕΡΙΓΡΑΦΗ ΕΤΑΙΡΕΙΑΣ Ν.3816 ΧΟΝ∆ΡΙΚΗ ΝΟΣΟΚΟΜΕΙΑΚΗ Ν.ΧΟΝ∆ΡΙΚΗ ΛΙΑΝΙΚΗ

46 55151 248402601ARANESP INJ.SOL. 150MCG/0,3ML PF.PEN BTx1PF.PENx0,3ML (SURE CLICK)

063 ΓΕΝΕΣΙΣ ΦΑΡΜΑ ΑΕ N 257,33 223,88 229,48 288,39

47 55152 248401901ARANESP INJ.SOL. 20MCG/0,5ML PF.PEN BTx1PF.PENx0,5ML (SURE CLICK)

063 ΓΕΝΕΣΙΣ ΦΑΡΜΑ ΑΕ N 33,18 28,87 29,59 37,19

48 55153 248402701ARANESP INJ.SOL. 300MCG/0,6ML PF.PEN BTx1PF.PENx0,6ML (SURE CLICK)

063 ΓΕΝΕΣΙΣ ΦΑΡΜΑ ΑΕ N 501,75 436,52 447,43 562,29

49 55154 248402101ARANESP INJ.SOL. 40MCG/0,4ML PF.PEN BTx1PF.PENx0,4ML (SURE CLICK)

063 ΓΕΝΕΣΙΣ ΦΑΡΜΑ ΑΕ N 71,66 62,34 63,90 80,30

50 55155 248402801ARANESP INJ.SOL. 500MCG/1ML PF.PEN BTx1PF.PENx1ML (SURE CLICK)

063 ΓΕΝΕΣΙΣ ΦΑΡΜΑ ΑΕ N 775,03 674,28 691,14 868,56

51 55156 248402301ARANESP INJ.SOL. 60MCG/0,3ML PF.PEN BTx1PF.PENx0,3ML (SURE CLICK)

063 ΓΕΝΕΣΙΣ ΦΑΡΜΑ ΑΕ N 108,85 94,70 97,07 121,99

52 55157 248402401ARANESP INJ.SOL. 80MCG/0,4ML PF.PEN BTx1PF.PENx0,4ML (SURE CLICK)

063 ΓΕΝΕΣΙΣ ΦΑΡΜΑ ΑΕ N 130,05 113,14 115,97 145,74

53 54700 248401101ARANESP INJ.SOL.1PF.SYRx300MCG/0,6ML

063 ΓΕΝΕΣΙΣ ΦΑΡΜΑ ΑΕ N 465,92 405,35 415,48 522,13

54 57314 248400905ARANESP SOLUTION FOR INJECTION 100MCG/0,5ML PF.SYR./ BTx4PF.SYR with needle guard

023 AMGEN EUROPE N 617,52 537,24 550,67 692,03

55 57315 248401005ARANESP SOLUTION FOR INJECTION 150MCG/0,3ML PF.SYR./ BTx4PF.SYR with needle guard

023 AMGEN EUROPE N 950,44 826,88 847,55 1065,12

56 57316 248400305ARANESP SOLUTION FOR INJECTION 20MCG/0,5ML PF.SYR./ BTx4PF.SYR with needle guard

023 AMGEN EUROPE N 127,68 111,08 113,86 143,09

57 57317 248401104ARANESP SOLUTION FOR INJECTION 300MCG/0,6ML PF.SYR./ BTx1PF.SYR with needle guard

023 AMGEN EUROPE N 465,92 405,35 415,48 522,13

58 57318 248400405ARANESP SOLUTION FOR INJECTION 30MCG/0,3ML PF.SYR./ BTx4PF.SYR with needle guard

023 AMGEN EUROPE N 194,87 169,54 173,78 218,39

59 57319 248400505ARANESP SOLUTION FOR INJECTION 40MCG/0,4ML PF.SYR./ BTx4PF.SYR with needle guard

023 AMGEN EUROPE N 246,36 214,33 219,69 276,08

60 57320 248401604ARANESP SOLUTION FOR INJECTION 500MCG/1ML PF.SYR./BTx1PF.SYR with needle guard

023 AMGEN EUROPE N 775,03 674,28 691,14 868,56

Page 4 of 46

Page 5: Κ ΑΡΧΕΙΟΥ Α Κ ΕΟΦ ΟΝΟΜΑΣΙΑ Κ ΕΤ ΠΕΡΙΓΡΑΦΗ … · 62 57322 248400705 aranesp solution for injection 60mcg/0,3ml pf.syr./ btx4pf.syr with needle guard

Α/ΑΚΩ∆. ΑΡΧΕΙΟΥ

ΓΓΕ ΚΩ∆. ΕΟΦ ΟΝΟΜΑΣΙΑ ΚΩ∆. ΕΤ. ΠΕΡΙΓΡΑΦΗ ΕΤΑΙΡΕΙΑΣ Ν.3816 ΧΟΝ∆ΡΙΚΗ ΝΟΣΟΚΟΜΕΙΑΚΗ Ν.ΧΟΝ∆ΡΙΚΗ ΛΙΑΝΙΚΗ

61 57321 248400605ARANESP SOLUTION FOR INJECTION 50MCG/0,5ML PF.SYR./ BTx4PF.SYR with needle guard

023 AMGEN EUROPE N 307,94 267,91 274,61 345,10

62 57322 248400705ARANESP SOLUTION FOR INJECTION 60MCG/0,3ML PF.SYR./ BTx4PF.SYR with needle guard

023 AMGEN EUROPE N 380,74 331,24 339,52 426,67

63 57323 248400805ARANESP SOLUTION FOR INJECTION 80MCG/0,4ML PF.SYR./ BTx4PF.SYR with needle guard

023 AMGEN EUROPE N 511,41 444,93 456,05 573,12

64 56758 294030102ARZERRA CS.SOL.INF 20MG/VIAL BTx10VIALSx5ML

411 GLAXO SMITHKLINΕ AEBE N 2291,54 1993,64 2043,48 2568,04

65 56759 294030101ARZERRA CS.SOL.INF 20MG/VIAL BTx3 VIALSx5ML

411 GLAXO SMITHKLINΕ AEBE N 694,08 603,85 618,95 777,83

66 55861 279190101ATRIANCE INJ.SOL. 5MG/ML VIAL BTx6 VIALx50ML

491GLAXO GROUP LTD, ENGLAND

N 1897,43 1650,76 1692,03 2126,37

67 55168 267690201AVASTIN CS. SOL. INF 25MG/ML BTx1VIALx16ML (400MG/16ML)

315 ROCHE EΛΛAΣ ΑΕ N 1233,44 1073,09 1099,92 1382,27

68 55169 267690101AVASTIN CS. SOL. INF 25MG/ML BTx1VIALx4ML (100MG/4ML)

315 ROCHE EΛΛAΣ ΑΕ N 325,82 283,46 290,55 365,13

69 54905 227250201 AVONEX INJ.SOL 4 PF SYRx30MCG/0,5ML 063 ΓΕΝΕΣΙΣ ΦΑΡΜΑ ΑΕ N 772,26 671,87 688,67 865,45

70 52938 227250102AVONEX PS.INJ.SOL 4VIALx30MCG/3ML+4PF.SYR

063 ΓΕΝΕΣΙΣ ΦΑΡΜΑ ΑΕ N 610,60 531,22 544,50 684,27

71 14959 287370101AXOPLAN CS.SOL.INF 5MG/1ML BTx1VIALx10ML

686 ALAPIS ABEE N 131,03 114,00 116,85 146,85

72 14960 287370102AXOPLAN CS.SOL.INF 5MG/1ML BTx1VIALx20ML

686 ALAPIS ABEE N 251,32 218,65 224,12 281,65

73 55469 273340102BARACLUDE F.C.TAB 0,5MG/TAB BTx30TABS

461BRISTOL MYERS PHARMA EEIG

N 389,43 338,80 347,27 436,41

74 55470 273340202BARACLUDE F.C.TAB 1MG/TAB BTx30TABS

461BRISTOL MYERS PHARMA EEIG

N 425,31 370,02 379,27 476,63

75 53284 233770301BENEFIX PS.INJ.SOL 1VIALx1000IU/10ML+1VIALx10ML SOLV ANA IU

295 PFIZER HELLAS ΑΕ N 0,82 0,71 0,73 0,92

Page 5 of 46

Page 6: Κ ΑΡΧΕΙΟΥ Α Κ ΕΟΦ ΟΝΟΜΑΣΙΑ Κ ΕΤ ΠΕΡΙΓΡΑΦΗ … · 62 57322 248400705 aranesp solution for injection 60mcg/0,3ml pf.syr./ btx4pf.syr with needle guard

Α/ΑΚΩ∆. ΑΡΧΕΙΟΥ

ΓΓΕ ΚΩ∆. ΕΟΦ ΟΝΟΜΑΣΙΑ ΚΩ∆. ΕΤ. ΠΕΡΙΓΡΑΦΗ ΕΤΑΙΡΕΙΑΣ Ν.3816 ΧΟΝ∆ΡΙΚΗ ΝΟΣΟΚΟΜΕΙΑΚΗ Ν.ΧΟΝ∆ΡΙΚΗ ΛΙΑΝΙΚΗ

76 53282 233770101BENEFIX PS.INJ.SOL 1VIALx250IU/5ML+1VIALx5ML SOLV ANA IU

295 PFIZER HELLAS ΑΕ N 0,82 0,71 0,73 0,92

77 53283 233770201BENEFIX PS.INJ.SOL 1VIALx500IU/5ML+1VIALx5ML SOLV ANA IU

295 PFIZER HELLAS ΑΕ N 0,82 0,71 0,73 0,92

78 55863 233770302BENEFIX PS.INJ.SOL.1000IU/ 1VIAL BTx 1VIAL +1PF.SYRx5ML SOLV + ΣΕΤ ΕΓΧΥΣΗΣ

295 PFIZER HELLAS ΑΕ N 472,49 411,07 421,35 529,51

79 56463 233770401BENEFIX PS.INJ.SOL.2000IU/ 1VIAL BTx1VIAL+1PF.SYRx5ML SOLV+ΣΕΤ ΕΓΧΥΣΗΣ

489 WYETH EUROPA LTD, UK N 944,99 822,14 842,69 1059,01

80 55864 233770202BENEFIX PS.INJ.SOL.500IU/ 1VIAL BTx 1VIAL + 1PF.SYRx5ML SOLV + ΣΕΤ ΕΓΧΥΣΗΣ

295 PFIZER HELLAS ΑΕ N 236,24 205,53 210,67 264,75

81 56762 284530101BERINERT P.SV INJ.F 500U/VIAL BTx1 VIALx500 U +1 VIALx10ML SOLV +USER KIT

438 CSL BEHRING Μ.ΕΠΕ N 524,70 456,49 467,90 588,01

82 54092 238900101BEROMUN PS.SO.INF BTx 4 VIALSx1MG+4 S0LV

214BOEHRINGER INGELHEIM ΑΕ

N 8367,49 7279,72 7461,71 9377,13

83 52820 223850103BETAFERON LY PD INJ 0,3 MG/VIAL BT 15 VIALS +15 PF.SYRX 2 ML SOLV

569BAYER SHERING PHARMA AG

N 701,80 610,57 625,83 786,48

84 56464 223850108BETAFERON PS.INJ.SOL 0,25MG/ML 12BTx1VIALx1PF.SYRx1,2ML SOLV+1πρ µε βελ+2τα

569BAYER SHERING PHARMA AG

N 532,21 463,02 474,60 596,43

85 55767 223850105BETAFERON PS.INJ.SOL BTx(15BTx1VIAL+1PF.SYRx1,2ML SOLV+1προσαρµ µε βελ+2ταµ

569BAYER SHERING PHARMA AG

N 762,08 663,01 679,59 854,04

86 56763 284351102 BINOCRIT 20000 IU/0.5l - Βt x 6 339 SANDOZ GMBH AUSTRIA N 672,74 585,28 599,91 753,91

87 56764 284351202 BINOCRIT 30000 IU/0.5l - Bt x 6 339 SANDOZ GMBH AUSTRIA N 1009,08 877,90 899,85 1130,84

88 56765 284351302 BINOCRIT 40000 IU/0.5l - Bt x 6 339 SANDOZ GMBH AUSTRIA N 1345,45 1170,54 1199,80 1507,79

89 56224 284350802BINOCRIT INJ.SOL 10000IU/1,0ML PF.SYR. BTx6

339 SANDOZ GMBH AUSTRIA N 336,37 292,64 299,96 376,96

90 56225 284350102BINOCRIT INJ.SOL 1000IU/0,5ML PF.SYR. BTx6

339 SANDOZ GMBH AUSTRIA N 33,26 28,94 29,66 37,27

Page 6 of 46

Page 7: Κ ΑΡΧΕΙΟΥ Α Κ ΕΟΦ ΟΝΟΜΑΣΙΑ Κ ΕΤ ΠΕΡΙΓΡΑΦΗ … · 62 57322 248400705 aranesp solution for injection 60mcg/0,3ml pf.syr./ btx4pf.syr with needle guard

Α/ΑΚΩ∆. ΑΡΧΕΙΟΥ

ΓΓΕ ΚΩ∆. ΕΟΦ ΟΝΟΜΑΣΙΑ ΚΩ∆. ΕΤ. ΠΕΡΙΓΡΑΦΗ ΕΤΑΙΡΕΙΑΣ Ν.3816 ΧΟΝ∆ΡΙΚΗ ΝΟΣΟΚΟΜΕΙΑΚΗ Ν.ΧΟΝ∆ΡΙΚΗ ΛΙΑΝΙΚΗ

91 56226 284350202BINOCRIT INJ.SOL 2000IU/1ML PF.SYR. BTx6

339 SANDOZ GMBH AUSTRIA N 67,28 58,53 59,99 75,39

92 56227 284350302BINOCRIT INJ.SOL 3000IU/0,3ML PF.SYR. BTx6VIALx0,3ML

339 SANDOZ GMBH AUSTRIA N 100,91 87,79 89,98 113,08

93 56228 284350402BINOCRIT INJ.SOL 4000IU/0,4ML PF.SYR. BTx6

339 SANDOZ GMBH AUSTRIA N 134,55 117,06 119,99 150,79

94 56229 284350502BINOCRIT INJ.SOL 5000IU/0,5ML PF.SYR. BTx6

339 SANDOZ GMBH AUSTRIA N 168,20 146,33 149,99 188,49

95 56230 284350602BINOCRIT INJ.SOL 6000IU/0,6ML PF.SYR. BTx6

339 SANDOZ GMBH AUSTRIA N 201,83 175,59 179,98 226,18

96 56231 284350702BINOCRIT INJ.SOL 8000IU/0,8ML PF.SYR. BTx6

339 SANDOZ GMBH AUSTRIA N 269,09 234,11 239,96 301,56

97 41932 253950103BIOTAXEL CS.SOL.INF 6MG/1ML BTx1 VIAL (150MG) x 25ML (MULTIDOSE)

223 MEDICUS ΑΕ N 285,82 248,66 254,88 320,31

98 41933 253950104BIOTAXEL CS.SOL.INF 6MG/1ML BTx1 VIAL (300MG) x 50ML (MULTIDOSE)

223 MEDICUS ΑΕ N 623,68 542,60 556,17 698,94

99 41487 253950102BIOTAXEL SOLUTION FOR INJ BTx1VIAL (100MG)x16,7ML (MULTIDOSE)

223 MEDICUS ΑΕ N 215,70 187,66 192,35 241,73

100 41488 253950101BIOTAXEL SOLUTION FOR INJ. BTx1VIAL (30MG)x5ML (MONODOSE)

223 MEDICUS ΑΕ N 67,11 58,39 59,85 75,21

101 42272 281540101BIOTECAN CS.SOL.INF 20MG/1ML BTx1VIAL x 2ML

223 MEDICUS ΑΕ N 51,67 44,95 46,07 57,90

102 42273 281540102BIOTECAN CS.SOL.INF 20MG/1ML BTx1VIAL x 5ML

223 MEDICUS ΑΕ N 129,16 112,37 115,18 144,75

103 42288 281540103BIOTECAN CS.SOL.INF. 20MG/1ML X1VIAL X 25ML

223 MEDICUS ΑΕ N 568,32 494,44 506,80 636,90

104 55942 272110103BRAMITOB INH.SOL.N (S.D) 300MG/4ML BTx56 (14 SACHETSx4AMPSx4ML µιας δόσης)

148 CHIESI HELLAS AEBE N 1685,38 1466,28 1502,94 1888,74

105 56293 264610102BUSILVEX C.S. SOL.INF 6MG/ML BT x 8VIALS x 10ML

291 PIERRE FABRE FARMAKA N 2556,23 2223,92 2279,52 2864,67

Page 7 of 46

Page 8: Κ ΑΡΧΕΙΟΥ Α Κ ΕΟΦ ΟΝΟΜΑΣΙΑ Κ ΕΤ ΠΕΡΙΓΡΑΦΗ … · 62 57322 248400705 aranesp solution for injection 60mcg/0,3ml pf.syr./ btx4pf.syr with needle guard

Α/ΑΚΩ∆. ΑΡΧΕΙΟΥ

ΓΓΕ ΚΩ∆. ΕΟΦ ΟΝΟΜΑΣΙΑ ΚΩ∆. ΕΤ. ΠΕΡΙΓΡΑΦΗ ΕΤΑΙΡΕΙΑΣ Ν.3816 ΧΟΝ∆ΡΙΚΗ ΝΟΣΟΚΟΜΕΙΑΚΗ Ν.ΧΟΝ∆ΡΙΚΗ ΛΙΑΝΙΚΗ

106 52944 225810101CAELYX CONCENTR.INF.INJ (IV) 1FLx10MLx2MG/ML

476 SP.EUROPE N 363,24 316,02 323,92 407,07

107 52946 232710301CAMPTO CS.SOL.INF 20MG/ML BTx1VIALx2ML (GLASS BOTTLE)

295 PFIZER HELLAS ΑΕ N 57,41 49,95 51,20 64,34

108 52945 232710302CAMPTO CS.SOL.INF 20MG/ML BTx1VIALx5ML (GLASS BOTTLE)

295 PFIZER HELLAS ΑΕ N 143,51 124,85 127,97 160,82

109 56371 232710304CAMPTO CS.SOL.INF. 20MG/ML BTx1 VIALx 15ML (PP BOTTLE)

295 PFIZER HELLAS ΑΕ N 430,54 374,57 383,93 482,48

110 56372 232710305CAMPTO CS.SOL.INF. 20MG/ML BTx1 VIALx 2ML (PP BOTTLE)

295 PFIZER HELLAS ΑΕ N 57,41 49,95 51,20 64,34

111 56373 232710303CAMPTO CS.SOL.INF. 20MG/ML BTx1 VIALx 5ML (PP BOTTLE)

295 PFIZER HELLAS ΑΕ N 143,51 124,85 127,97 160,82

112 57132 292510102CAYSTON PS.SO.INHN 75 MG/VIAL 84 VIALS+88AMPS (PE) x 1ML SOLV +1 συσκευή του εκνεφωτή ALTERA

068 GILEAD N 3198,68 2782,85 2852,42 3584,64

113 57133 293170105CEDOL C/S SOL. IN 6MG/ML BOX x 1VIAL x 100MG

064 GAP AE N 194,14 168,90 173,12 217,56

114 57134 293170103CEDOL C/S SOL. IN 6MG/ML BOX x 1VIAL x 300MG

064 GAP AE N 561,32 488,35 500,56 629,05

115 57135 293170101CEDOL C/S SOL. IN 6MG/ML BOX x 1VIAL x 30MG

064 GAP AE N 60,41 52,56 53,87 67,70

116 57136 293170104CEDOL C/S SOL. IN 6MG/ML BTx 10 BOXES x 1VIAL x 100MG

064 GAP AE N 1941,41 1689,03 1731,26 2175,67

117 57137 293170106CEDOL C/S SOL. IN 6MG/ML BTx 10 BOXES x 1VIAL x 300MG

064 GAP AE N 5613,22 4883,50 5005,59 6290,52

118 57138 293170102CEDOL C/S SOL. IN 6MG/ML BTx 10 BOXES x 1VIAL x 30MG

064 GAP AE N 604,09 525,56 538,70 676,98

119 52555 225540101 CELLCEPT CAPS BT 100X250 MG 315 ROCHE EΛΛAΣ ΑΕ N 85,71 74,57 76,43 96,05

120 53686 225540401CELLCEPT CS.SOL.INF. 4VIALx500MG/20ML

315 ROCHE EΛΛAΣ ΑΕ N 55,01 47,86 49,06 61,65

Page 8 of 46

Page 9: Κ ΑΡΧΕΙΟΥ Α Κ ΕΟΦ ΟΝΟΜΑΣΙΑ Κ ΕΤ ΠΕΡΙΓΡΑΦΗ … · 62 57322 248400705 aranesp solution for injection 60mcg/0,3ml pf.syr./ btx4pf.syr with needle guard

Α/ΑΚΩ∆. ΑΡΧΕΙΟΥ

ΓΓΕ ΚΩ∆. ΕΟΦ ΟΝΟΜΑΣΙΑ ΚΩ∆. ΕΤ. ΠΕΡΙΓΡΑΦΗ ΕΤΑΙΡΕΙΑΣ Ν.3816 ΧΟΝ∆ΡΙΚΗ ΝΟΣΟΚΟΜΕΙΑΚΗ Ν.ΧΟΝ∆ΡΙΚΗ ΛΙΑΝΙΚΗ

121 53926 225540301 CELLCEPT PD.OR.SOL 1G/5ML FL.110G 315 ROCHE EΛΛAΣ ΑΕ N 129,51 112,67 115,49 145,14

122 52961 225540201 CELLCEPT TABL 50x500MG 315 ROCHE EΛΛAΣ ΑΕ N 85,26 74,18 76,03 95,55

123 56048 234950201CEREZYME PD.SOL. INF 400U/VIAL BTx1 VIAL

465GENZYME BV, NEDERLAND

N 1708,95 1486,79 1523,96 1915,16

124 55182 234950101CEREZYME PD.SOL.INF200U/VIAL BTx1 VIAL

465GENZYME BV, NEDERLAND

N 861,84 749,80 768,55 965,84

125 55021 261570102 CERTICAN TABL BT 60x0,25MG 321 NOVARTIS HELLAS AEΒΕ N 107,74 93,73 96,07 120,73

126 55022 261570202 CERTICAN TABL BT 60x0,50MG 321 NOVARTIS HELLAS AEΒΕ N 221,51 192,71 197,53 248,24

127 55023 261570302 CERTICAN TABL BT 60x0,75MG 321 NOVARTIS HELLAS AEΒΕ N 319,97 278,37 285,33 358,57

128 55183 261570402 CERTICAN TABL BT 60x1MG (BLIST 6x10) 321 NOVARTIS HELLAS AEΒΕ N 516,26 449,15 460,38 578,56

129 55024 261570602 CERTICAN TABL. DISP BT 60x0,25MG 321 NOVARTIS HELLAS AEΒΕ N 107,74 93,73 96,07 120,73

130 56774 291450101CIMZIA Ενέσιµο διάλυµα 200MG BTx2 PF.SYRx1ML+2 τολύπια εµποτισµένα µε οινόπ

500 UCB S.A. N 943,55 820,89 841,41 1057,40

131 55197 252570201COPAXONE INJ. SOL 20MG/1ML BT 28PF. SYRx1ML

431TEVA PHARMACEUTICALS LTD

N 662,91 576,73 591,15 742,90

132 54793 257320103 COPEGUS F.C.TABL 112x200MG 315 ROCHE EΛΛAΣ ΑΕ N 286,55 249,30 255,53 321,12

133 54794 257320104 COPEGUS F.C.TABL 168x200MG 315 ROCHE EΛΛAΣ ΑΕ N 514,06 447,23 458,41 576,08

134 54795 257320101 COPEGUS F.C.TABL 28x200MG 315 ROCHE EΛΛAΣ ΑΕ N 77,46 67,39 69,07 86,80

135 54796 257320102 COPEGUS F.C.TABL 42x200MG 315 ROCHE EΛΛAΣ ΑΕ N 113,84 99,04 101,52 127,58

Page 9 of 46

Page 10: Κ ΑΡΧΕΙΟΥ Α Κ ΕΟΦ ΟΝΟΜΑΣΙΑ Κ ΕΤ ΠΕΡΙΓΡΑΦΗ … · 62 57322 248400705 aranesp solution for injection 60mcg/0,3ml pf.syr./ btx4pf.syr with needle guard

Α/ΑΚΩ∆. ΑΡΧΕΙΟΥ

ΓΓΕ ΚΩ∆. ΕΟΦ ΟΝΟΜΑΣΙΑ ΚΩ∆. ΕΤ. ΠΕΡΙΓΡΑΦΗ ΕΤΑΙΡΕΙΑΣ Ν.3816 ΧΟΝ∆ΡΙΚΗ ΝΟΣΟΚΟΜΕΙΑΚΗ Ν.ΧΟΝ∆ΡΙΚΗ ΛΙΑΝΙΚΗ

136 56051 257320202COPEGUS FC. TAB 400MG/TAB BTx1 BOTTLE x 56

315 ROCHE EΛΛAΣ ΑΕ N 343,01 298,42 305,88 384,40

137 40892 197690101 CYMEVENE INJ LYO. FL 12x500MG IV 315 ROCHE EΛΛAΣ ΑΕ N 175,43 152,62 156,44 196,60

138 52557 197690102 CYMEVENE LY.PD.INJ.IV FL 500 MG 315 ROCHE EΛΛAΣ ΑΕ N 21,15 18,40 18,86 23,70

139 56840 293810101DOCETAXEL TEVA C.SO.S.INF 20 MG/0,72 ML VIAL (1 VIAL x 0,72 ML + 1 VIAL x 1,28 ML SOLV)

644 TEVA PHARMA B.V. N 126,74 110,26 113,02 142,03

140 56841 293810201DOCETAXEL TEVA C.SO.S.INF 80 MG/2,88 ML VIAL (1 VIAL x 2,88 ML + 1 VIAL x 5,12 ML SOLV)

644 TEVA PHARMA B.V. N 492,25 428,26 438,97 551,65

141 57378 278810103DOCETAXEL/HOSPIRA, C/S.SOL.IN 10MG/ML, BT x 1VIALX16ML (160MG/16ML)

654 HOSPIRA UK LTD N 920,38 800,73 820,75 1031,44

142 57379 278810102DOCETAXEL/HOSPIRA, C/S.SOL.IN 10MG/ML, BT x 1VIALX8ML (80MG/8ML)

654 HOSPIRA UK LTD N 492,25 428,26 438,97 551,65

143 57380 278810101DOCETAXEL/HOSPIRA, C/S.SOL.IN, 10MG/ML, BT x 1VIALX2ML (20MG/2ML)

654 HOSPIRA UK LTD N 126,74 110,26 113,02 142,03

144 56133 267530101DUODOPA ENT. GEL (20+5)MG/ML BTx7 BAGSx100ML (BAG από PVC)

505SOLVAY PHARM/CALS GMBH

N 797,01 693,40 710,74 893,19

145 55875 277020101ELAPRASE CS.SOL.INF 2MG/ML 1 VIALx3ML

555SHIRE HUMAN THERAPIES AB

N 3090,66 2688,87 2756,09 3463,58

146 55786 269890202ELOXATIN C.S.SOL.INF 5MG/ML BTx1(VIALx100MGx20ML)

518 SANOFI-AVENTIS AEBE N 279,24 242,94 249,01 312,93

147 55787 269890201ELOXATIN C.S.SOL.INF 5MG/ML BTx1(VIALx50MGx10ML)

518 SANOFI-AVENTIS AEBE N 145,59 126,66 129,83 163,16

148 56617 244601002ENBREL INJ.SOL.PF.PEN 50MG/ML BTx4 x 1ML + 8 τολύπια

489 WYETH EUROPA LTD, UK N 976,84 849,85 871,10 1094,71

149 55693 244600801ENBREL NJ.SOL 25MG/0,5ML PF.SYR BTx4 PF.SYRx0,5ML + 8 τολύπια

295 PFIZER HELLAS ΑΕ N 518,48 451,08 462,36 581,05

150 55694 244600902ENBREL NJ.SOL 50MG/1ML PF.SYR BTx4 PF.SYRx1ML + 8 τολύπια

295 PFIZER HELLAS ΑΕ N 1017,26 885,02 907,15 1140,02

Page 10 of 46

Page 11: Κ ΑΡΧΕΙΟΥ Α Κ ΕΟΦ ΟΝΟΜΑΣΙΑ Κ ΕΤ ΠΕΡΙΓΡΑΦΗ … · 62 57322 248400705 aranesp solution for injection 60mcg/0,3ml pf.syr./ btx4pf.syr with needle guard

Α/ΑΚΩ∆. ΑΡΧΕΙΟΥ

ΓΓΕ ΚΩ∆. ΕΟΦ ΟΝΟΜΑΣΙΑ ΚΩ∆. ΕΤ. ΠΕΡΙΓΡΑΦΗ ΕΤΑΙΡΕΙΑΣ Ν.3816 ΧΟΝ∆ΡΙΚΗ ΝΟΣΟΚΟΜΕΙΑΚΗ Ν.ΧΟΝ∆ΡΙΚΗ ΛΙΑΝΙΚΗ

151 53937 244600101 ENBREL PS INJ 4 VIALSx25MG+4 SYR 295 PFIZER HELLAS ΑΕ N 375,22 326,44 334,60 420,49

152 55217 244600602ENBREL PS. INJ.SOL 50MG VIALx 4 + 4 PF + 4 ΒΕΛ. + 4 ΠΡΟΣΑΡΜΟΓΕΣ + 8 ΤΟΛΥΠΙΑ

295 PFIZER HELLAS ΑΕ N 777,09 676,07 692,97 870,86

153 54885 244600102ENBREL PS.INJ 4VIALSx25MG+ 4P.F SYR+8NEEDLES

295 PFIZER HELLAS ΑΕ N 483,67 420,79 431,31 542,03

154 55695 244600701ENBREL PS.INJ.SOL 25MG/VIAL-ΓΙΑ ΠΑΙ∆. ΧΡΗΣΗ BTx4VIALS+4PF.SYRX1ML SOL+....

295 PFIZER HELLAS ΑΕ N 508,45 442,35 453,41 569,80

155 57390 295250605EPORATIO, INJ.SOL (προγεµισµένη σύριγγα) 10.000 IU/1ML, BTx6 PF.SYR x 1ML (χωρίς συσκευή ασφαλείας)

727 RATIOPHARM GMBH N 340,98 296,65 304,07 382,12

156 57391 295250101EPORATIO, INJ.SOL (προγεµισµένη σύριγγα) 1000 IU/0,5ML, BTx6 PF.SYR x 0,5ML (χωρίς συσκευή ασφαλείας)

727 RATIOPHARM GMBH N 37,92 32,99 33,81 42,49

157 57392 295250701EPORATIO, INJ.SOL (προγεµισµένη σύριγγα) 20.000 IU/1ML, BTx1PF.SYR x 1ML (χωρίς συσκευή ασφαλείας)

727 RATIOPHARM GMBH N 113,69 98,91 101,38 127,40

158 57393 295250705EPORATIO, INJ.SOL (προγεµισµένη σύριγγα) 20.000 IU/1ML, BTx6 PF.SYR x 1ML (χωρίς συσκευή ασφαλείας)

727 RATIOPHARM GMBH N 682,24 593,55 608,39 764,56

159 57394 295250201EPORATIO, INJ.SOL (προγεµισµένη σύριγγα) 2000 IU/0,5ML, BTx6 PF.SYR x 0,5ML (χωρίς συσκευή ασφαλείας)

727 RATIOPHARM GMBH N 70,94 61,72 63,26 79,50

160 57395 295250801EPORATIO, INJ.SOL (προγεµισµένη σύριγγα) 30.000 IU/1ML, BTx1PF.SYR x 1ML (χωρίς συσκευή ασφαλείας)

727 RATIOPHARM GMBH N 170,86 148,65 152,37 191,48

161 57396 295250803EPORATIO, INJ.SOL (προγεµισµένη σύριγγα) 30.000 IU/1ML, BTx4 PF.SYR x 1ML (χωρίς συσκευή ασφαλείας)

727 RATIOPHARM GMBH N 683,45 594,60 609,47 765,92

162 57397 295250301EPORATIO, INJ.SOL (προγεµισµένη σύριγγα) 3000 IU/0,5ML, BTx6 PF.SYR x 0,5ML (χωρίς συσκευή ασφαλείας)

727 RATIOPHARM GMBH N 110,43 96,07 98,47 123,75

163 57398 295250401EPORATIO, INJ.SOL (προγεµισµένη σύριγγα) 4000 IU/0,5ML, BTx6 PF.SYR x 0,5ML (χωρίς συσκευή ασφαλείας)

727 RATIOPHARM GMBH N 142,97 124,38 127,49 160,22

164 57399 295250501EPORATIO, INJ.SOL (προγεµισµένη σύριγγα) 5000 IU/0,5ML, BTx6 PF.SYR x 0,5ML (χωρίς συσκευή ασφαλείας)

727 RATIOPHARM GMBH N 186,17 161,97 166,02 208,64

165 51838 196470302 EPREX INJ FL 6VIALx10000IU/ML IV 061 JANSSEN-CILAG ΑΕΒΕ N 462,54 402,41 412,47 518,35

Page 11 of 46

Page 12: Κ ΑΡΧΕΙΟΥ Α Κ ΕΟΦ ΟΝΟΜΑΣΙΑ Κ ΕΤ ΠΕΡΙΓΡΑΦΗ … · 62 57322 248400705 aranesp solution for injection 60mcg/0,3ml pf.syr./ btx4pf.syr with needle guard

Α/ΑΚΩ∆. ΑΡΧΕΙΟΥ

ΓΓΕ ΚΩ∆. ΕΟΦ ΟΝΟΜΑΣΙΑ ΚΩ∆. ΕΤ. ΠΕΡΙΓΡΑΦΗ ΕΤΑΙΡΕΙΑΣ Ν.3816 ΧΟΝ∆ΡΙΚΗ ΝΟΣΟΚΟΜΕΙΑΚΗ Ν.ΧΟΝ∆ΡΙΚΗ ΛΙΑΝΙΚΗ

166 52325 196470401 EPREX INJ FL 6x1000 IU/0,5ML 061 JANSSEN-CILAG ΑΕΒΕ N 46,18 40,18 41,18 51,75

167 52480 196470402 EPREX INJ FL 6x1000IU/0.5ML IV 061 JANSSEN-CILAG ΑΕΒΕ N 46,18 40,18 41,18 51,75

168 52481 196470601 EPREX INJ FL 6x2000 IU/0,5 ML IV 061 JANSSEN-CILAG ΑΕΒΕ N 100,34 87,30 89,48 112,45

169 51716 196470102 EPREX INJ FL 6X2000 IU/ML IV 061 JANSSEN-CILAG ΑΕΒΕ N 100,34 87,30 89,48 112,45

170 51539 196470202 EPREX INJ FL 6X4000 IU/ML IV 061 JANSSEN-CILAG ΑΕΒΕ N 191,14 166,29 170,45 214,20

171 53938 196470901 EPREX INJ SOL 1 VIALx40000 IU/ML 061 JANSSEN-CILAG ΑΕΒΕ N 302,38 263,07 269,65 338,87

172 53939 196470902 EPREX INJ SOL 4 VIALSx40000 IU/ML 061 JANSSEN-CILAG ΑΕΒΕ N 1028,45 894,75 917,12 1152,54

173 53940 196470903 EPREX INJ SOL 6 VIALSx40000 IU/ML 061 JANSSEN-CILAG ΑΕΒΕ N 1560,62 1357,74 1391,68 1748,92

174 54420 196471001 EPREX INJ SOL 6PF SYRx5000IU/0,5ML 061 JANSSEN-CILAG ΑΕΒΕ N 242,97 211,38 216,66 272,28

175 54421 196471101 EPREX INJ SOL 6PF SYRx6000IU/0,6ML 061 JANSSEN-CILAG ΑΕΒΕ N 284,20 247,25 253,43 318,49

176 54422 196471201 EPREX INJ SOL 6PF SYRx7000IU/0,7ML 061 JANSSEN-CILAG ΑΕΒΕ N 273,02 237,53 243,47 305,97

177 54423 196471301 EPREX INJ SOL 6PF SYRx8000IU/0,8ML 061 JANSSEN-CILAG ΑΕΒΕ N 383,03 333,24 341,57 429,25

178 54424 196471401 EPREX INJ SOL 6PF SYRx9000IU/0,9ML 061 JANSSEN-CILAG ΑΕΒΕ N 351,14 305,49 313,13 393,51

179 53660 196470801 EPREX INJ SOL 6PF.SYRx4000IU/0.4ML 061 JANSSEN-CILAG ΑΕΒΕ N 191,14 166,29 170,45 214,20

180 56385 196471701EPREX INJ.SO.PFS 30.000IU/0,75ML PF.SYR BTx1PF.SYRx0,75ML

061 JANSSEN-CILAG ΑΕΒΕ N 266,24 231,63 237,42 298,37

Page 12 of 46

Page 13: Κ ΑΡΧΕΙΟΥ Α Κ ΕΟΦ ΟΝΟΜΑΣΙΑ Κ ΕΤ ΠΕΡΙΓΡΑΦΗ … · 62 57322 248400705 aranesp solution for injection 60mcg/0,3ml pf.syr./ btx4pf.syr with needle guard

Α/ΑΚΩ∆. ΑΡΧΕΙΟΥ

ΓΓΕ ΚΩ∆. ΕΟΦ ΟΝΟΜΑΣΙΑ ΚΩ∆. ΕΤ. ΠΕΡΙΓΡΑΦΗ ΕΤΑΙΡΕΙΑΣ Ν.3816 ΧΟΝ∆ΡΙΚΗ ΝΟΣΟΚΟΜΕΙΑΚΗ Ν.ΧΟΝ∆ΡΙΚΗ ΛΙΑΝΙΚΗ

181 56386 196471702EPREX INJ.SO.PFS 30.000IU/0,75ML PF.SYR BTx4PF.SYRx0,75ML

061 JANSSEN-CILAG ΑΕΒΕ N 740,40 644,15 660,25 829,74

182 56387 196471703EPREX INJ.SO.PFS 30.000IU/0,75ML PF.SYR BTx6PF.SYRx0,75ML

061 JANSSEN-CILAG ΑΕΒΕ N 1110,59 966,21 990,37 1244,60

183 55696 196471601EPREX INJ.SOL 20000IU/0,5ML PF.SYR. BTx1PF.SYRx0,5ML

061 JANSSEN-CILAG ΑΕΒΕ N 166,55 144,90 148,52 186,65

184 55697 196471602EPREX INJ.SOL 20000IU/0,5ML PF.SYR. BTx4PF.SYRx0,5ML

061 JANSSEN-CILAG ΑΕΒΕ N 518,45 451,05 462,33 581,01

185 55698 196471603EPREX INJ.SOL 20000IU/0,5ML PF.SYR. BTx6PF.SYRx0,5ML

061 JANSSEN-CILAG ΑΕΒΕ N 999,30 869,39 891,12 1119,87

186 52482 196470701EPREX INJ.SOL 3000IV/0,3ML BT 6PF .SYR X0,3ML

061 JANSSEN-CILAG ΑΕΒΕ N 143,37 124,73 127,85 160,67

187 55699 196471501EPREX INJ.SOL 40000IU/1ML PF.SYR. BTx1PF.SYRx1ML

061 JANSSEN-CILAG ΑΕΒΕ N 299,90 260,91 267,43 336,08

188 55700 196471502EPREX INJ.SOL 40000IU/1ML PF.SYR. BTx4PF.SYRx1ML

061 JANSSEN-CILAG ΑΕΒΕ N 1199,60 1043,65 1069,74 1344,34

189 55701 196471503EPREX INJ.SOL 40000IU/1ML PF.SYR. BTx6PF.SYRx1ML

061 JANSSEN-CILAG ΑΕΒΕ N 1799,40 1565,48 1604,62 2016,53

190 52479 196470303 EPREX ΙΝJ FL 6x10.000 IU/ML IV 061 JANSSEN-CILAG ΑΕΒΕ N 462,54 402,41 412,47 518,35

191 52679 220060101ETHYOL PD.SOL.INF 500MG/VIAL BTx3 VIALx500MG

636PINNACLE BIOLOGICALS B.V.

N 499,63 434,68 445,55 559,92

192 56620 286010105EVOLTRA C.S.SOL.INF 20MG(1MG/ML) 20ML VIAL BTx1 VIAL

465GENZYME BV, NEDERLAND

N 1704,45 1482,87 1519,94 1910,11

193 56389 286010102EVOLTRA CS.INJ.SOL. 20MG(1MG/ML)/20ML VIAL BTx4 VIALS

465GENZYME BV, NEDERLAND

N 7000,00 6090,00 6242,25 7844,64

194 55504 274460101EXJADE DISP.TAB. 125MG/TAB BTx28 (BLIST 4x7)

517NOVARTIS EUROPHARM LTD

N 188,07 163,62 167,71 210,76

195 55505 274460201EXJADE DISP.TAB. 250MG/TAB BTx28 (BLIST 4x7)

517NOVARTIS EUROPHARM LTD

N 388,61 338,09 346,54 435,50

Page 13 of 46

Page 14: Κ ΑΡΧΕΙΟΥ Α Κ ΕΟΦ ΟΝΟΜΑΣΙΑ Κ ΕΤ ΠΕΡΙΓΡΑΦΗ … · 62 57322 248400705 aranesp solution for injection 60mcg/0,3ml pf.syr./ btx4pf.syr with needle guard

Α/ΑΚΩ∆. ΑΡΧΕΙΟΥ

ΓΓΕ ΚΩ∆. ΕΟΦ ΟΝΟΜΑΣΙΑ ΚΩ∆. ΕΤ. ΠΕΡΙΓΡΑΦΗ ΕΤΑΙΡΕΙΑΣ Ν.3816 ΧΟΝ∆ΡΙΚΗ ΝΟΣΟΚΟΜΕΙΑΚΗ Ν.ΧΟΝ∆ΡΙΚΗ ΛΙΑΝΙΚΗ

196 55506 274460301EXJADE DISP.TAB. 500MG/TAB BTx28 (BLIST 4x7)

517NOVARTIS EUROPHARM LTD

N 743,09 646,49 662,65 832,75

197 56390 284330103EXTAVIA PS.INJ.SOL 250MCG/ML 3x15VIALS+3x15PF.SYRSx1,2ML SOLV

517NOVARTIS EUROPHARM LTD

N 1896,28 1649,76 1691,00 2125,08

198 56391 284330102EXTAVIA PS.INJ.SOL 250MCG/ML BTx15VIALS+15PF.SYRSx1,2ML SOLV

517NOVARTIS EUROPHARM LTD

N 783,99 682,07 699,12 878,58

199 56060 250220201FABRAZYME PD.INJ.SOL IV 5MG/VIAL BTx1VIAL

465GENZYME BV, NEDERLAND

N 506,26 440,45 451,46 567,35

200 55509 250220101FABRAZYME PD.INJ.SOL IV BTx1VIALx35MG/VIAL

465GENZYME BV, NEDERLAND

N 3543,87 3083,17 3160,25 3971,49

201 53821 247490101 FERRIPROX F.C.TABL 100x500MG 079 DEMO AE N 171,61 149,30 153,03 192,31

202 56151 247490202FERRIPROX OR.SOL. 500MG/5ML (100MG/ML) PLASTIC BOTTLEx500ML

616 APOTEX EUROPE B.V. N 180,02 156,62 160,54 201,75

203 56392 286460101FIRAZYR INJ.SOL. 30MG/3ML PF.SYRx3ML (10MG/ML) BTx1PF.SYR.x3ML+1βελόνα

656 JERINI AG N 1749,55 1522,11 1560,16 1960,65

204 53692 226790103FLEBOGAMMA SOL IV INF 5% 1VIALx100ML

079 DEMO AE N 186,97 162,66 166,73 209,53

205 53693 226790101 FLEBOGAMMA SOL IV INF 5% 1VIALx10ML 079 DEMO AE N 18,89 16,43 16,84 21,16

206 53694 226790104FLEBOGAMMA SOL IV INF 5% 1VIALx200ML

079 DEMO AE N 379,60 330,25 338,51 425,41

207 53695 226790102 FLEBOGAMMA SOL IV INF 5% 1VIALx50ML 079 DEMO AE N 93,84 81,64 83,68 105,16

208 57423 289970103FLEBOGAMMADIF SOL INF 50MG/ML BT 1VIALx100ML

079 DEMO ABEE N 287,00 249,69 255,93 321,63

209 57424 289970104FLEBOGAMMADIF SOL INF 50MG/ML BT 1VIALx200ML

079 DEMO ABEE N 574,00 499,38 511,86 643,25

210 57425 289970105FLEBOGAMMADIF SOL INF 50MG/ML BT 1VIALx400ML

079 DEMO ABEE N 1148,00 998,76 1023,73 1286,52

Page 14 of 46

Page 15: Κ ΑΡΧΕΙΟΥ Α Κ ΕΟΦ ΟΝΟΜΑΣΙΑ Κ ΕΤ ΠΕΡΙΓΡΑΦΗ … · 62 57322 248400705 aranesp solution for injection 60mcg/0,3ml pf.syr./ btx4pf.syr with needle guard

Α/ΑΚΩ∆. ΑΡΧΕΙΟΥ

ΓΓΕ ΚΩ∆. ΕΟΦ ΟΝΟΜΑΣΙΑ ΚΩ∆. ΕΤ. ΠΕΡΙΓΡΑΦΗ ΕΤΑΙΡΕΙΑΣ Ν.3816 ΧΟΝ∆ΡΙΚΗ ΝΟΣΟΚΟΜΕΙΑΚΗ Ν.ΧΟΝ∆ΡΙΚΗ ΛΙΑΝΙΚΗ

211 57426 289970102FLEBOGAMMADIF SOL INF 50MG/ML BT 1VIALx50ML

079 DEMO ABEE N 143,51 124,85 127,97 160,82

212 54605 221540201 FLUDARA F.C.TABL BT 15x10MG 465GENZYME BV, NEDERLAND

N 313,64 272,87 279,69 351,49

213 54606 221540202 FLUDARA F.C.TABL BT 20x10MG 465GENZYME BV, NEDERLAND

N 415,33 361,34 370,37 465,44

214 52704 221540101 FLUDARA LY.PD.INJ.BT5VIALSX50MG 465GENZYME BV, NEDERLAND

N 609,03 529,86 543,11 682,53

215 56477 275480103FLUDARABIN/EBEWE INJ.SOL/CS.SOL.INF 25MG/ML BTx10VIALSx2ML

564 EBEWE PHARMA GMBH N 1096,25 953,74 977,58 1228,52

216 56478 275480101FLUDARABIN/EBEWE INJ.SOL/CS.SOL.INF 25MG/ML BTx1VIALx2ML

564 EBEWE PHARMA GMBH N 109,63 95,38 97,76 122,85

217 56479 275480102FLUDARABIN/EBEWE INJ.SOL/CS.SOL.INF 25MG/ML BTx5VIALSx2ML

564 EBEWE PHARMA GMBH N 548,13 476,87 488,79 614,26

218 54803 247360201 FOSCAN INJ.IV.SOL 1VIALx5MLx4MG/ML 063 ΓΕΝΕΣΙΣ ΦΑΡΜΑ ΑΕ N 4554,16 3962,12 4061,17 5103,67

219 56305 271830103GAMINEX SOL. INF 100MG/ML (10% W/V) BTx1VIAL x 100ML

079 DEMO AE N 530,13 461,21 472,74 594,09

220 56306 271830101GAMINEX SOL. INF 100MG/ML (10% W/V) BTx1VIAL x 10ML

079 DEMO AE N 55,49 48,28 49,49 62,19

221 56307 271830104GAMINEX SOL. INF 100MG/ML (10% W/V) BTx1VIAL x 200ML

079 DEMO AE N 1090,71 948,92 972,64 1222,32

222 56308 271830102GAMINEX SOL. INF 100MG/ML (10% W/V) BTx1VIAL x 50ML

079 DEMO AE N 265,06 230,60 236,37 297,05

223 53030 220120301GAMMAGARD SD LY.PD.INJ 1BOTTLEx5G+1BOTTLEx96ML SOLV

034 BAXTER HELLAS ΕΠΕ N 226,54 197,09 202,02 253,88

224 57771 298250103GILENYA CAPS 0.5mg BTx28 PVC/PVDC/alu

321 NOVARTIS HELLAS AEΒΕ N 1930,00 1679,10 1721,08 2162,88

225 54804 245110101 GLIADEL IMPLANT BT 8x7,7MG 063 ΓΕΝΕΣΙΣ ΦΑΡΜΑ ΑΕ N 6987,28 6078,93 6230,90 7830,37

Page 15 of 46

Page 16: Κ ΑΡΧΕΙΟΥ Α Κ ΕΟΦ ΟΝΟΜΑΣΙΑ Κ ΕΤ ΠΕΡΙΓΡΑΦΗ … · 62 57322 248400705 aranesp solution for injection 60mcg/0,3ml pf.syr./ btx4pf.syr with needle guard

Α/ΑΚΩ∆. ΑΡΧΕΙΟΥ

ΓΓΕ ΚΩ∆. ΕΟΦ ΟΝΟΜΑΣΙΑ ΚΩ∆. ΕΤ. ΠΕΡΙΓΡΑΦΗ ΕΤΑΙΡΕΙΑΣ Ν.3816 ΧΟΝ∆ΡΙΚΗ ΝΟΣΟΚΟΜΕΙΑΚΗ Ν.ΧΟΝ∆ΡΙΚΗ ΛΙΑΝΙΚΗ

226 57306 293490101GLIOLAN 30MG/ML - POWDER FOR ORAL SOLUTION-1.5G-1 VIAL

620 MEDAC GMBH, GERMANY N 1126,40 979,97 1004,47 1262,32

227 54504 253440204 GLIVEC CAPS BT 120x100MG 321 NOVARTIS HELLAS AEΒΕ N 2355,51 2049,29 2100,52 2639,72

228 55033 253440402 GLIVEC F.C.TABL BT 30x400MG 321 NOVARTIS HELLAS AEΒΕ N 2477,49 2155,42 2209,31 2776,44

229 55034 253440302 GLIVEC F.C.TABL BT 60x100MG 321 NOVARTIS HELLAS AEΒΕ N 1231,64 1071,53 1098,32 1380,26

230 52264 209760102GRANOCYTE PS.INJ.SOL 33,6MIU(263mcg)BTx5VIALS+5AMPSx1ML SOLV

518 SANOFI-AVENTIS AEBE N 348,75 303,41 311,00 390,83

231 52263 209760101GRANOCYTE PS.INJ.SOL 33,6MIU(263mcg)BTxVIAL+1AMPx1ML SOLV

518 SANOFI-AVENTIS AEBE N 46,45 40,41 41,42 52,05

232 56309 209760110GRANOCYTE PS.INJ.SOL.33,6MIU (263MCG)/VIAL BTx5VIALS+5PF.SYRx1ML SOLV

518 SANOFI-AVENTIS AEBE N 348,75 303,41 311,00 390,83

233 55239 201240902GRANULOKINE INJ.SOL 5 PF SYRx30MU(300MCG)/0,5ML

023 AMGEN EUROPE B.V. N 316,67 275,50 282,39 354,88

234 55240 201241002GRANULOKINE INJ.SOL 5 PF SYRx48MU(480MCG)/0,5ML

023 AMGEN EUROPE B.V. N 520,51 452,84 464,16 583,31

235 51899 201240101GRANULOKINE INJ.SOL. 30MU(300MCG)/1ML VIAL BTx5VIALSx1ML

023 AMGEN EUROPE B.V. N 321,82 279,98 286,98 360,65

236 51900 201240201GRANULOKINE INJ.SOL.48MU(480MCG)/1,6ML VIAL BTx5VIALSx1,6ML

023 AMGEN EUROPE B.V. N 610,01 530,71 543,98 683,62

237 54893 259970101 HEPSERA TABL FL 30x10MG 068 GILEAD N 417,31 363,06 372,14 467,67

238 53953 245730101 HERCEPTIN PS CO INF 1 VIALx150MG 315 ROCHE EΛΛAΣ ΑΕ N 581,91 506,26 518,92 652,13

239 54916 256960201HUMIRA SOL.INJ. 1PF SYR 40MG/0,8ML+ALCOHOL PAD

512 ABBOTT LABOR. LTD N 484,91 421,87 432,42 543,42

240 56152 230540301HYCAMTIN CAPS 0,25MG/CAP BTx10 σε BLIST (PVC/PCTFE/ALU)

488SMITHKLINE BEECHAM PLC

N 110,18 95,86 98,26 123,48

Page 16 of 46

Page 17: Κ ΑΡΧΕΙΟΥ Α Κ ΕΟΦ ΟΝΟΜΑΣΙΑ Κ ΕΤ ΠΕΡΙΓΡΑΦΗ … · 62 57322 248400705 aranesp solution for injection 60mcg/0,3ml pf.syr./ btx4pf.syr with needle guard

Α/ΑΚΩ∆. ΑΡΧΕΙΟΥ

ΓΓΕ ΚΩ∆. ΕΟΦ ΟΝΟΜΑΣΙΑ ΚΩ∆. ΕΤ. ΠΕΡΙΓΡΑΦΗ ΕΤΑΙΡΕΙΑΣ Ν.3816 ΧΟΝ∆ΡΙΚΗ ΝΟΣΟΚΟΜΕΙΑΚΗ Ν.ΧΟΝ∆ΡΙΚΗ ΛΙΑΝΙΚΗ

241 56153 230540401HYCAMTIN CAPS 1MG/CAP BTx10 σε BLIST (PVC/PCTFE/ALU)

488SMITHKLINE BEECHAM PLC

N 395,80 344,35 352,96 443,56

242 53055 230540103 HYCAMTIN DR.PD.INJ 1VIALx4MG/5ML 411 GLAXO SMITHKLINΕ AEBE N 187,07 162,75 166,82 209,64

243 53056 230540101 HYCAMTIN DR.PD.INJ 5VIALx4MG/5ML IV 411 GLAXO SMITHKLINΕ AEBE N 1322,05 1150,18 1178,93 1481,56

244 55853 272140103IG VENA SOL.IV.INF 0,05G/ML BOTTLEx100ML + Σετ έγχυσης

540KEDRION SPA LUCCA ITALY

N 324,00 281,88 288,93 363,10

245 55854 272140104IG VENA SOL.IV.INF 0,05G/ML BOTTLEx200ML + Σετ έγχυσης

540KEDRION SPA LUCCA ITALY

N 647,99 563,75 577,84 726,17

246 55851 272140101IG VENA SOL.IV.INF 0,05G/ML BOTTLEx20ML

540KEDRION SPA LUCCA ITALY

N 64,80 56,38 57,79 72,62

247 55852 272140102IG VENA SOL.IV.INF 0,05G/ML BOTTLEx50ML + Σετ έγχυσης

540KEDRION SPA LUCCA ITALY

N 162,00 140,94 144,46 181,54

248 56909 291660101 ILARIS PD.INJ.SOL 150MG BTx1VIAL 517NOVARTIS EUROPHARM LTD

N 11539,64 10039,49 10290,48 12932,05

249 52199 203940101 IMUKIN INJ FL 0.1 MG/0.5ML SC 214BOEHRINGER INGELHEIM ΑΕ

N 84,77 73,75 75,59 94,99

250 56216 280800101 INCRELEX INJ.SOL 10MG/ML 1VIALx4ML 712 IPSEN PHARMA FRANCE N 680,00 591,60 606,39 762,05

251 56239 283740101INOVELON F.C. TAB 100MG/TAB BTx10 σε BLISTERS (PA/AL/PVC)

633 EISAI LTD N 5,59 4,86 4,98 6,26

252 56240 283740204INOVELON F.C. TAB 200MG/TAB BTx60 σε BLISTERS (PA/AL/PVC)

633 EISAI LTD N 64,85 56,42 57,83 72,67

253 56241 283740304INOVELON F.C. TAB 400MG/TAB BTx60 σε BLISTERS (PA/AL/PVC)

633 EISAI LTD N 115,95 100,88 103,40 129,94

254 53429 209420102INTRAGLOBIN-F SOL IV INF 5% 1AMPx10ML

212 BIOTEST ΕΛΛΑΣ Μ.Ε.Π.Ε. N 24,62 21,42 21,96 27,60

255 53430 209420103INTRAGLOBIN-F SOL IV INF 5% 1AMPx20ML

212 BIOTEST ΕΛΛΑΣ Μ.Ε.Π.Ε. N 46,90 40,80 41,82 52,56

Page 17 of 46

Page 18: Κ ΑΡΧΕΙΟΥ Α Κ ΕΟΦ ΟΝΟΜΑΣΙΑ Κ ΕΤ ΠΕΡΙΓΡΑΦΗ … · 62 57322 248400705 aranesp solution for injection 60mcg/0,3ml pf.syr./ btx4pf.syr with needle guard

Α/ΑΚΩ∆. ΑΡΧΕΙΟΥ

ΓΓΕ ΚΩ∆. ΕΟΦ ΟΝΟΜΑΣΙΑ ΚΩ∆. ΕΤ. ΠΕΡΙΓΡΑΦΗ ΕΤΑΙΡΕΙΑΣ Ν.3816 ΧΟΝ∆ΡΙΚΗ ΝΟΣΟΚΟΜΕΙΑΚΗ Ν.ΧΟΝ∆ΡΙΚΗ ΛΙΑΝΙΚΗ

256 53431 209420105INTRAGLOBIN-F SOL IV INF 5% 1ΦΙΑΛΗ ΕΚΧΥΣΗΣx100ML+SET

212 BIOTEST ΕΛΛΑΣ Μ.Ε.Π.Ε. N 176,51 153,56 157,40 197,80

257 53432 209420106INTRAGLOBIN-F SOL IV INF 5% 1ΦΙΑΛΗ ΕΚΧΥΣΗΣx200ML+SET

212 BIOTEST ΕΛΛΑΣ Μ.Ε.Π.Ε. N 309,60 269,35 276,08 346,95

258 53433 209420104INTRAGLOBIN-F SOL IV INF 5% 1ΦΙΑΛΗ ΕΚΧΥΣΗΣx50ML+SET

212 BIOTEST ΕΛΛΑΣ Μ.Ε.Π.Ε. N 81,37 70,79 72,56 91,19

259 56159 269270103INTRATECT SOL.IV.INF 50MG/ML VIALx100ML

212 BIOTEST ΕΛΛΑΣ Μ.Ε.Π.Ε. N 300,00 261,00 267,53 336,20

260 56160 269270104INTRATECT SOL.IV.INF 50MG/ML VIALx200ML

212 BIOTEST ΕΛΛΑΣ Μ.Ε.Π.Ε. N 595,00 517,65 530,59 666,79

261 56161 269270101INTRATECT SOL.IV.INF 50MG/ML VIALx20ML

212 BIOTEST ΕΛΛΑΣ Μ.Ε.Π.Ε. N 60,90 52,98 54,30 68,24

262 56162 269270102INTRATECT SOL.IV.INF 50MG/ML VIALx50ML

212 BIOTEST ΕΛΛΑΣ Μ.Ε.Π.Ε. N 152,00 132,24 135,55 170,35

263 53972 245610701 INTRONA INJ SOL 1VIAL x 10MIU/1ML 476 SP.EUROPE N 53,00 46,11 47,26 59,39

264 53973 245610901INTRONA INJ SOL 1VIAL x 25MIU/2,5ML MULTIDOSE

476 SP.EUROPE N 137,57 119,69 122,68 154,17

265 53974 245610501 INTRONA INJ SOL 1VIAL x 3MIU/0,5ML 476 SP.EUROPE N 13,02 11,33 11,61 14,59

266 53975 245610601 INTRONA INJ SOL 1VIAL x 5MIU/0,5ML 476 SP.EUROPE N 20,57 17,90 18,35 23,06

267 53976 245611001INTRONA INJ SOL 18 MIU/1,2ML PEN MULTIDOSE

476 SP.EUROPE N 73,25 63,73 65,32 82,09

268 53977 245611101INTRONA INJ SOL 30 MIU/1,2ML PEN MULTIDOSE

476 SP.EUROPE N 119,14 103,65 106,24 133,51

269 53978 245611201INTRONA INJ SOL 60 MIU/1,2ML PEN MULTIDOSE

476 SP.EUROPE N 238,29 207,31 212,49 267,04

270 54506 245610801 INTRONA INJ SOL VIALx18MIU/3ML 476 SP.EUROPE N 92,83 80,76 82,78 104,03

Page 18 of 46

Page 19: Κ ΑΡΧΕΙΟΥ Α Κ ΕΟΦ ΟΝΟΜΑΣΙΑ Κ ΕΤ ΠΕΡΙΓΡΑΦΗ … · 62 57322 248400705 aranesp solution for injection 60mcg/0,3ml pf.syr./ btx4pf.syr with needle guard

Α/ΑΚΩ∆. ΑΡΧΕΙΟΥ

ΓΓΕ ΚΩ∆. ΕΟΦ ΟΝΟΜΑΣΙΑ ΚΩ∆. ΕΤ. ΠΕΡΙΓΡΑΦΗ ΕΤΑΙΡΕΙΑΣ Ν.3816 ΧΟΝ∆ΡΙΚΗ ΝΟΣΟΚΟΜΕΙΑΚΗ Ν.ΧΟΝ∆ΡΙΚΗ ΛΙΑΝΙΚΗ

271 53979 245610101 INTRONA PS INJ SOL 1MIU/VIAL + SOLV 476 SP.EUROPE N 4,66 4,05 4,15 5,22

272 53980 245611401 INTRONA PS INJ SOL 30MIU/VIAL + SOLV 476 SP.EUROPE N 119,14 103,65 106,24 133,51

273 56647 290950101IRESSA F.C. TAB 250mg/TAB, BT X 30 BLIST (PVC/ALU) 3x10

688 AstraZeneca AB N 2246,54 1954,49 2003,35 2517,61

274 15144 280230107IRINOTECAN/ GENERICS, CS.SOL.INF 20MG/ML, BTx15ML AMBER GLASS VIAL (300MG/15ML)

351GENERICS PHARMA HELLAS

N 348,74 303,40 310,99 390,82

275 15145 280230108IRINOTECAN/ GENERICS, CS.SOL.INF 20MG/ML, BTx25ML AMBER GLASS VIAL (500MG/25ML)

351GENERICS PHARMA HELLAS

N 511,49 445,00 456,13 573,22

276 56739 280230101IRINOTECAN/GENERICS CS.SOL.INF 20MG/ML BTx1 VIALx2ML

351GENERICS PHAR.HELLAS ΕΠΕ

N 51,67 44,95 46,07 57,90

277 56740 280230104IRINOTECAN/GENERICS CS.SOL.INF 20MG/ML BTx1 VIALx5ML

351GENERICS PHAR.HELLAS ΕΠΕ

N 129,16 112,37 115,18 144,75

278 56492 275810101IRINOTECAN/TEVA CS.SOL.INF 20MG/ML BTx1 VIALx2ML

644 TEVA PHARMA B.V. N 51,67 44,95 46,07 57,90

279 56493 275810103IRINOTECAN/TEVA CS.SOL.INF 20MG/ML BTx1 VIALx5ML

644 TEVA PHARMA B.V. N 129,16 112,37 115,18 144,75

280 56494 275810102IRINOTECAN/TEVA CS.SOL.INF 20MG/ML BTx5 VIALSx2ML

644 TEVA PHARMA B.V. N 258,32 224,74 230,36 289,49

281 56495 275810104IRINOTECAN/TEVA CS.SOL.INF 20MG/ML BTx5 VIALSx5ML

644 TEVA PHARMA B.V. N 645,79 561,84 575,89 723,72

282 15002 284130201 IRITEC C/S SOL.IN 100MG/5ML BTx1VIAL 040 ΒΙΑΝΕΞ ΑΕ N 129,16 112,37 115,18 144,75

283 15003 284130101 IRITEC C/S SOL.IN 40MG/2ML BTx1VIAL 040 ΒΙΑΝΕΞ ΑΕ N 51,67 44,95 46,07 57,90

284 56930 291640105JAVLOR CS.SOL.INF 25MG/ML BTx1VIAL(µε γκρι ελαστικό πώµα) Χ10ml

291 PIERRE FABRE FARMAKA N 1165,20 1013,72 1039,06 1305,79

285 56931 291640101JAVLOR CS.SOL.INF 25MG/ML BTx1VIAL(µε γκρι ελαστικό πώµα) Χ2ml

291 PIERRE FABRE FARMAKA N 233,05 202,75 207,82 261,17

Page 19 of 46

Page 20: Κ ΑΡΧΕΙΟΥ Α Κ ΕΟΦ ΟΝΟΜΑΣΙΑ Κ ΕΤ ΠΕΡΙΓΡΑΦΗ … · 62 57322 248400705 aranesp solution for injection 60mcg/0,3ml pf.syr./ btx4pf.syr with needle guard

Α/ΑΚΩ∆. ΑΡΧΕΙΟΥ

ΓΓΕ ΚΩ∆. ΕΟΦ ΟΝΟΜΑΣΙΑ ΚΩ∆. ΕΤ. ΠΕΡΙΓΡΑΦΗ ΕΤΑΙΡΕΙΑΣ Ν.3816 ΧΟΝ∆ΡΙΚΗ ΝΟΣΟΚΟΜΕΙΑΚΗ Ν.ΧΟΝ∆ΡΙΚΗ ΛΙΑΝΙΚΗ

286 55281 270680101KEPIVANCE PD.INJ.SOL 6,25MG/VIAL BTx6VIALS

676 BIOVINTRUM AB N 4639,36 4036,24 4137,15 5199,16

287 54616 249950103KINERET INJ.SOL 28PF.SYRx100MG/0,67ML

676 BIOVINTRUM AB N 841,49 732,10 750,40 943,03

288 55528 272050104KIOVIG SOL.IV.INF 100MG/ML BTx1VIALx100ML

462 BAXTER AG N 466,00 405,42 415,56 522,23

289 55529 272050101KIOVIG SOL.IV.INF 100MG/ML BTx1VIALx10ML

462 BAXTER AG N 46,60 40,54 41,55 52,22

290 55530 272050105KIOVIG SOL.IV.INF 100MG/ML BTx1VIALx200ML

462 BAXTER AG N 932,00 810,84 831,11 1044,46

291 55531 272050102KIOVIG SOL.IV.INF 100MG/ML BTx1VIALx25ML

462 BAXTER AG N 116,51 101,36 103,89 130,56

292 55532 272050103KIOVIG SOL.IV.INF 100MG/ML BTx1VIALx50ML

462 BAXTER AG N 233,00 202,71 207,78 261,12

293 56496 287120101 KUVAN SOLU.TAB 100MG/TAB BOTTLEx30 504MERCK KGAA DEUTSCHLAND

N 741,29 644,92 661,04 830,73

294 52758 222130101LEUSTATIN INJ SO INF 10MG/10ML BT 7VIALS X 10ML

061 JANSSEN-CILAG ΑΕΒΕ N 2000,37 1740,32 1783,83 2241,74

295 56313 258020101 LITAK INJ.SOL 2MG/ML BTx1 VIALx5ML 640 LIPOMED GMBH N 339,89 295,70 303,09 380,89

296 56314 258020102 LITAK INJ.SOL 2MG/ML BTx5 VIALx5ML 640 LIPOMED GMBH N 1570,70 1366,51 1400,67 1760,22

297 55714 276920101LUCENTIS INJ.SOL 10MG/ML BTx1VIAL 2,3MG/0,23ML

517NOVARTIS EUROPHARM LTD

N 945,51 822,59 843,15 1059,59

298 55302 270120101LYSODREN TABL 500MG/TAB FL (HDPE)x100

472 LAB.HRA PHARMA N 648,53 564,22 578,33 726,79

299 55715 249030201MAB CAMPATH CS.SOL.INF 30MG/ML BTx3 VIALSx1ML

465GENZYME BV, NEDERLAND

N 1101,76 958,53 982,49 1234,70

300 54438 249030101MAB CAMPATH CS.SOL.INF 3AMP 3MLx10MG/ML

465GENZYME BV, NEDERLAND

N 998,64 868,82 890,54 1119,14

Page 20 of 46

Page 21: Κ ΑΡΧΕΙΟΥ Α Κ ΕΟΦ ΟΝΟΜΑΣΙΑ Κ ΕΤ ΠΕΡΙΓΡΑΦΗ … · 62 57322 248400705 aranesp solution for injection 60mcg/0,3ml pf.syr./ btx4pf.syr with needle guard

Α/ΑΚΩ∆. ΑΡΧΕΙΟΥ

ΓΓΕ ΚΩ∆. ΕΟΦ ΟΝΟΜΑΣΙΑ ΚΩ∆. ΕΤ. ΠΕΡΙΓΡΑΦΗ ΕΤΑΙΡΕΙΑΣ Ν.3816 ΧΟΝ∆ΡΙΚΗ ΝΟΣΟΚΟΜΕΙΑΚΗ Ν.ΧΟΝ∆ΡΙΚΗ ΛΙΑΝΙΚΗ

301 53463 235640201MABTHERA CON.SOL INF IV 1VIALx500MG/50ML

315 ROCHE EΛΛAΣ ΑΕ N 1259,97 1096,17 1123,57 1411,99

302 53464 235640101MABTHERA CON.SOL INF IV 2VIALx100MG/10ML

315 ROCHE EΛΛAΣ ΑΕ N 501,17 436,02 446,92 561,64

303 55977 271900102MACUGEN SOL.INJ. 0,3MG/PF.SYR BTx1PF.SYR 90µL + προγεµισµ.συρ. χωρίς βελόνα

470 PFIZER LTD, UK N 589,25 512,65 525,47 660,36

304 55536 271900101MACUGEN SOL.INJ. 0,3MG/PF.SYR BTx1PF.SYR 90µL +εµβολο+δακτ.σταθεροποίησης

470 PFIZER LTD, UK N 589,25 512,65 525,47 660,36

305 53469 220170104MEGALOTECT SOL IV INF 50U/ML 1 ΓΥΑΛΙΝΗ ΦΙΑΛΗ ΕΚΧΥΣΗΣx50ML

212 BIOTEST ΕΛΛΑΣ Μ.Ε.Π.Ε. N 447,86 389,64 399,38 501,90

306 53470 220170102MEGALOTECT SOL IV INF 50U/ML 1AMPx10ML

212 BIOTEST ΕΛΛΑΣ Μ.Ε.Π.Ε. N 80,99 70,46 72,22 90,76

307 53471 220170103MEGALOTECT SOL IV INF 50U/ML 1AMPx20ML

212 BIOTEST ΕΛΛΑΣ Μ.Ε.Π.Ε. N 161,41 140,43 143,94 180,89

308 57520 294650101MEPACT, Κόνις για εναιώρηµα προς έγχυση 4mg/VIAL, 1 VIAL + 1 ΦΙΛΤΡΟ

728 IDM PHARMA S.A.S N 3335,79 2902,14 2974,69 3738,29

309 55983 279041001MIRCERA INJ.SOL 100MCG/0,3ML PF.SYR BTx1PF.SYR

487ROCHE REGISTRATION LTD,UK

N 204,71 178,10 182,55 229,41

310 56320 279042001MIRCERA INJ.SOL 120MCG/0,3ML PF.SYR BTx1PF.SYRx0,3ML

487ROCHE REGISTRATION LTD,UK

N 258,02 224,48 230,09 289,15

311 55984 279041101MIRCERA INJ.SOL 150MCG/0,3ML PF.SYR BTx1PF.SYR

487ROCHE REGISTRATION LTD,UK

N 328,57 285,86 293,01 368,23

312 55985 279041201MIRCERA INJ.SOL 200MCG/0,3ML PF.SYR BTx1PF.SYR

487ROCHE REGISTRATION LTD,UK

N 400,66 348,57 357,28 448,99

313 55986 279041301MIRCERA INJ.SOL 250MCG/0,3ML PF.SYR BTx1PF.SYR

487ROCHE REGISTRATION LTD,UK

N 490,44 426,68 437,35 549,62

314 56321 279041701MIRCERA INJ.SOL 30MCG/0,3ML PF.SYR BTx1PF.SYRx0,3ML

487ROCHE REGISTRATION LTD,UK

N 65,37 56,87 58,29 73,25

315 56322 279042101MIRCERA INJ.SOL 360MCG/0,6ML PF.SYR BTx1PF.SYRx0,6ML

487ROCHE REGISTRATION LTD,UK

N 721,20 627,44 643,13 808,22

Page 21 of 46

Page 22: Κ ΑΡΧΕΙΟΥ Α Κ ΕΟΦ ΟΝΟΜΑΣΙΑ Κ ΕΤ ΠΕΡΙΓΡΑΦΗ … · 62 57322 248400705 aranesp solution for injection 60mcg/0,3ml pf.syr./ btx4pf.syr with needle guard

Α/ΑΚΩ∆. ΑΡΧΕΙΟΥ

ΓΓΕ ΚΩ∆. ΕΟΦ ΟΝΟΜΑΣΙΑ ΚΩ∆. ΕΤ. ΠΕΡΙΓΡΑΦΗ ΕΤΑΙΡΕΙΑΣ Ν.3816 ΧΟΝ∆ΡΙΚΗ ΝΟΣΟΚΟΜΕΙΑΚΗ Ν.ΧΟΝ∆ΡΙΚΗ ΛΙΑΝΙΚΗ

316 55987 279040801MIRCERA INJ.SOL 50MCG/0,3ML PF.SYR BTx1PF.SYR

487ROCHE REGISTRATION LTD,UK

N 100,17 87,15 89,33 112,26

317 55988 279040901MIRCERA INJ.SOL 75MCG/0,3ML PF.SYR BTx1PF.SYR

487ROCHE REGISTRATION LTD,UK

N 144,51 125,72 128,86 161,94

318 42378 286220103MIZANTRONE CS.SOL.INF 20MG/ML BT x 1VIAL x 15ML

055 VOCATE AE N 348,74 303,40 310,99 390,82

319 42379 286220101MIZANTRONE CS.SOL.INF 20MG/ML BT x 1VIAL x 2ML

055 VOCATE AE N 46,51 40,46 41,47 52,12

320 42380 286220102MIZANTRONE CS.SOL.INF 20MG/ML BT x 1VIAL x 5ML

055 VOCATE AE N 116,25 101,14 103,67 130,28

321 56679 291630101MOZOBIL INJ.SOL 20MG/ML BTx1VIALx24MG/1,2ML

465GENZYME BV, NEDERLAND

N 6301,51 5482,31 5619,37 7061,86

322 53105 225180101MUPHORAN DR.PD.INJ 1VIALx208MG+1AMPx4ML SOLV

324 SERVIER HELLAS ΕΠΕ N 454,53 395,44 405,33 509,38

323 57249 294930101MYCOFEN/NEXUS CAPS 250MG/CAP BTx100(Blisters)

536 NEXUS MEDICALS A.E. N 83,18 72,37 74,18 93,22

324 56324 283640101MYFENAX CAPS 250MG/CAP BTx100 σε BLISTERS (PVC/PVDC/ALU)

644 TEVA PHARMA B.V. N 77,15 67,12 68,80 86,46

325 56325 283640201MYFENAX F.C. TAB 500MG/TAB BTx50 σε BLISTERS (PVC/PVDC/ALU)

644 TEVA PHARMA B.V. N 76,75 66,77 68,44 86,01

326 57535 283640102MYFENAX, CAPS 250MG/CAP, BTX300 BLISTER (PVC/PVDC/ALU)

644 TEVA PHARMA BV N 197,63 171,94 176,24 221,48

327 57536 283640202MYFENAX, F.C.TAB 500MG/TAB, BTX150 BLISTER (PVC/PVDC/ALU)

644 TEVA PHARMA BV N 197,63 171,94 176,24 221,48

328 42383 284830101MYFETIL CAPS 250MG/CAP BTx100(BLISTERS 10x10)

331 SPECIFAR ABEE N 76,75 66,77 68,44 86,01

329 42250 284830201 MYFETIL FC.TAB 500 MG/TAB BTx 50 TABS 331 SPECIFAR AΒΕE N 76,75 66,77 68,44 86,01

330 55321 262810105 MYFORTIC F.C. TABL BT 120x180MG 321 NOVARTIS HELLAS AEΒΕ N 136,51 118,76 121,73 152,98

Page 22 of 46

Page 23: Κ ΑΡΧΕΙΟΥ Α Κ ΕΟΦ ΟΝΟΜΑΣΙΑ Κ ΕΤ ΠΕΡΙΓΡΑΦΗ … · 62 57322 248400705 aranesp solution for injection 60mcg/0,3ml pf.syr./ btx4pf.syr with needle guard

Α/ΑΚΩ∆. ΑΡΧΕΙΟΥ

ΓΓΕ ΚΩ∆. ΕΟΦ ΟΝΟΜΑΣΙΑ ΚΩ∆. ΕΤ. ΠΕΡΙΓΡΑΦΗ ΕΤΑΙΡΕΙΑΣ Ν.3816 ΧΟΝ∆ΡΙΚΗ ΝΟΣΟΚΟΜΕΙΑΚΗ Ν.ΧΟΝ∆ΡΙΚΗ ΛΙΑΝΙΚΗ

331 55322 262810204 MYFORTIC F.C. TABL BT 120x360MG 321 NOVARTIS HELLAS AEΒΕ N 260,30 226,46 232,12 291,71

332 55049 251340101 MYOCET P.S.INJ.SOL.CON. 50MG 2 SET 408 WYETH EΛΛΑΣ ΑΕΒΕ N 1135,76 988,11 1012,81 1272,80

333 56075 272340101MYOZYME PD.SOL.INF. 50MG/VIAL BTx1VIAL

465GENZYME BV, NEDERLAND

N 602,97 524,58 537,69 675,72

334 52630 209850101 NAVELBINE INJ.SOL.BT 1 VIAL X10MG/ML 291 PIERRE FABRE FARMAKA N 18,08 15,73 16,12 20,26

335 52631 209850401 NAVELBINE INJ.SOL.BT 1 VIAL X50MG/ML 291 PIERRE FABRE FARMAKA N 85,44 74,33 76,19 95,75

336 54918 209850501 NAVELBINE SOFT. CAPS BT 1x20MG 291 PIERRE FABRE FARMAKA N 47,05 40,93 41,95 52,72

337 54919 209850601 NAVELBINE SOFT. CAPS BT 1x30MG 291 PIERRE FABRE FARMAKA N 69,83 60,75 62,27 78,25

338 54035 228961802NEORECORMON INJ SOL 6PF SYR 4000 IU x 0,3ML

315 ROCHE EΛΛAΣ ΑΕ N 202,77 176,41 180,82 227,24

339 54036 228961902NEORECORMON INJ SOL 6PF SYR 6000 IU x 0,3ML

315 ROCHE EΛΛAΣ ΑΕ N 304,34 264,78 271,40 341,07

340 54037 228960701NEORECORMON PS INJ SOL 1VIALx100000IU+SOLV 10ML+SYSK+SYR

315 ROCHE EΛΛAΣ ΑΕ N 656,67 571,30 585,58 735,90

341 54038 228960601NEORECORMON PS INJ SOL 1VIALx50000IU+SOLV 10ML+SYSK+SYR

315 ROCHE EΛΛAΣ ΑΕ N 328,33 285,65 292,79 367,95

342 54168 228961701NEORECORMON PS.INJ SOL 60000IU 1 CARTRx1ML

315 ROCHE EΛΛAΣ ΑΕ N 406,66 353,79 362,63 455,72

343 54169 228961702NEORECORMON PS.INJ SOL 60000IU 3 CARTRx1ML

315 ROCHE EΛΛAΣ ΑΕ N 1219,95 1061,36 1087,89 1367,15

344 53851 228960801NEORECORMON PS.INJ.SOL 10000IU 1CARTR.X1ml

315 ROCHE EΛΛAΣ ΑΕ N 66,79 58,11 59,56 74,85

345 53852 228960802NEORECORMON PS.INJ.SOL 10000IU 3CARTR.X1ml

315 ROCHE EΛΛAΣ ΑΕ N 195,03 169,68 173,92 218,57

Page 23 of 46

Page 24: Κ ΑΡΧΕΙΟΥ Α Κ ΕΟΦ ΟΝΟΜΑΣΙΑ Κ ΕΤ ΠΕΡΙΓΡΑΦΗ … · 62 57322 248400705 aranesp solution for injection 60mcg/0,3ml pf.syr./ btx4pf.syr with needle guard

Α/ΑΚΩ∆. ΑΡΧΕΙΟΥ

ΓΓΕ ΚΩ∆. ΕΟΦ ΟΝΟΜΑΣΙΑ ΚΩ∆. ΕΤ. ΠΕΡΙΓΡΑΦΗ ΕΤΑΙΡΕΙΑΣ Ν.3816 ΧΟΝ∆ΡΙΚΗ ΝΟΣΟΚΟΜΕΙΑΚΗ Ν.ΧΟΝ∆ΡΙΚΗ ΛΙΑΝΙΚΗ

346 53853 228960901NEORECORMON PS.INJ.SOL 20000IU 1CARTR.X1ml

315 ROCHE EΛΛAΣ ΑΕ N 135,55 117,93 120,88 151,91

347 53854 228960902NEORECORMON PS.INJ.SOL 20000IU 3CARTR.X1ml

315 ROCHE EΛΛAΣ ΑΕ N 406,66 353,79 362,63 455,72

348 53490 228961501NEORECORMON SOL INJ 1PF.SYR. 10000IUx0.6ML

315 ROCHE EΛΛAΣ ΑΕ N 67,46 58,69 60,16 75,60

349 53491 228961101NEORECORMON SOL INJ 1PF.SYR. 1000IUx0.3ML

315 ROCHE EΛΛAΣ ΑΕ N 7,11 6,19 6,34 7,97

350 53492 228961601NEORECORMON SOL INJ 1PF.SYR. 20000IUx0.6ML

315 ROCHE EΛΛAΣ ΑΕ N 131,33 114,26 117,12 147,18

351 53493 228961201NEORECORMON SOL INJ 1PF.SYR. 2000IUx0.3ML

315 ROCHE EΛΛAΣ ΑΕ N 14,47 12,59 12,90 16,21

352 53494 228961301NEORECORMON SOL INJ 1PF.SYR. 3000IUx0.3ML

315 ROCHE EΛΛAΣ ΑΕ N 20,91 18,19 18,64 23,42

353 53495 228961401NEORECORMON SOL INJ 1PF.SYR. 5000IUx0.3ML

315 ROCHE EΛΛAΣ ΑΕ N 34,63 30,13 30,88 38,81

354 53496 228961001NEORECORMON SOL INJ 1PF.SYR. 500IUx0.3ML

315 ROCHE EΛΛAΣ ΑΕ N 3,49 3,04 3,12 3,92

355 53497 228961502NEORECORMON SOL INJ 6PF.SYR. 10000IUx0.6ML

315 ROCHE EΛΛAΣ ΑΕ N 512,69 446,04 457,19 574,55

356 53498 228961102NEORECORMON SOL INJ 6PF.SYR. 1000IUx0.3ML

315 ROCHE EΛΛAΣ ΑΕ N 42,68 37,13 38,06 47,83

357 53499 228961602NEORECORMON SOL INJ 6PF.SYR. 20000IUx0.6ML

315 ROCHE EΛΛAΣ ΑΕ N 788,00 685,56 702,70 883,08

358 53500 228961202NEORECORMON SOL INJ 6PF.SYR. 2000IUx0.3ML

315 ROCHE EΛΛAΣ ΑΕ N 101,29 88,12 90,32 113,51

359 53501 228961302NEORECORMON SOL INJ 6PF.SYR. 3000IUx0.3ML

315 ROCHE EΛΛAΣ ΑΕ N 152,01 132,25 135,56 170,36

360 53502 228961402NEORECORMON SOL INJ 6PF.SYR. 5000IUx0.3ML

315 ROCHE EΛΛAΣ ΑΕ N 253,53 220,57 226,08 284,11

Page 24 of 46

Page 25: Κ ΑΡΧΕΙΟΥ Α Κ ΕΟΦ ΟΝΟΜΑΣΙΑ Κ ΕΤ ΠΕΡΙΓΡΑΦΗ … · 62 57322 248400705 aranesp solution for injection 60mcg/0,3ml pf.syr./ btx4pf.syr with needle guard

Α/ΑΚΩ∆. ΑΡΧΕΙΟΥ

ΓΓΕ ΚΩ∆. ΕΟΦ ΟΝΟΜΑΣΙΑ ΚΩ∆. ΕΤ. ΠΕΡΙΓΡΑΦΗ ΕΤΑΙΡΕΙΑΣ Ν.3816 ΧΟΝ∆ΡΙΚΗ ΝΟΣΟΚΟΜΕΙΑΚΗ Ν.ΧΟΝ∆ΡΙΚΗ ΛΙΑΝΙΚΗ

361 53503 228961002NEORECORMON SOL INJ 6PF.SYR. 500IUx0.3ML

315 ROCHE EΛΛAΣ ΑΕ N 20,92 18,20 18,66 23,45

362 55050 228962001NEORECORMON SOL.INJ. 1PF.SYR 30000IUx0,6ML

315 ROCHE EΛΛAΣ ΑΕ N 195,66 170,22 174,48 219,27

363 55051 228962002NEORECORMON SOL.INJ. 4PF.SYR 30000IUx0,6ML

315 ROCHE EΛΛAΣ ΑΕ N 994,95 865,61 887,25 1115,01

364 54812 258870101NEULASTA INJ.SOL. BT 1PF.SYR. 0,6MLx10MG/ML

063 ΓΕΝΕΣΙΣ ΦΑΡΜΑ ΑΕ N 894,45 778,17 797,62 1002,37

365 57539 258870103NEULASTA, INJ. SOL. PF.SYR , 6MG/0,6ML(10MG/ML) BTx1PF.SYR µε µηχαν.κάλυψης βελόνας

063 ΓΕΝΕΣΙΣ ΦΑΡΜΑ N 894,46 778,18 797,63 1002,38

366 55547 273490101NEXAVAR F.C.TAB 200MG/TAB BTx112 Blist (PP/ALU) 4x28

509 BAYER HEALTH CARE AG N 3674,55 3196,86 3276,78 4117,93

367 57543 295050202NIVESTIM, INJ.SO.INF 30MU (300MCG/0,5ML), 5PF.SYR x 0,5ML

654 HOSPIRA UK LTD N 232,07 201,90 206,95 260,07

368 57544 295050302NIVESTIM, INJ.SO.INF 48MU (480MCG/0,5ML), 5PF.SYR x 0,5ML

654 HOSPIRA UK LTD N 379,44 330,11 338,36 425,22

369 55325 223400201NOVOSEVEN INJ 1 VIALx2,4MG (120KIU)+1 VIAL SOLV (4,3ML)

243NOVO NORDISK HELLAS ΕΠΕ

N 1005,06 874,40 896,26 1126,33

370 56326 225400401NOVOSEVEN PS.INJ.SOL 1MG(50KIU)/VIAL BTx1VIAL + 1VIALx1,1ML SOLV

645 NOVO NORDISK A/S N 597,76 520,05 533,05 669,88

371 56327 223400501NOVOSEVEN PS.INJ.SOL 2MG(100KIU)/VIAL BTx1VIAL + 1VIALx2,1ML SOLV

645 NOVO NORDISK A/S N 1195,74 1040,29 1066,30 1340,02

372 57256 287230301NPLATE (Romiplostim) PD.INJ.SOL 250MCG/VIAL, BTx1VIAL

653 AMGEN EUROPE B.V. N 631,34 549,27 563,00 707,52

373 57257 287230302NPLATE (Romiplostim) PD.INJ.SOL 250MCG/VIAL, BTx4VIALS

653 AMGEN EUROPE B.V. N 2525,38 2197,08 2252,01 2830,10

374 57258 287230401NPLATE (Romiplostim) PD.INJ.SOL 500MCG/VIAL, BTx1VIAL

653 AMGEN EUROPE B.V. N 1290,97 1123,14 1151,22 1446,74

375 57259 287230402NPLATE (Romiplostim) PD.INJ.SOL 500MCG/VIAL, BTx4VIALS

653 AMGEN EUROPE B.V. N 5163,83 4492,53 4604,84 5786,90

Page 25 of 46

Page 26: Κ ΑΡΧΕΙΟΥ Α Κ ΕΟΦ ΟΝΟΜΑΣΙΑ Κ ΕΤ ΠΕΡΙΓΡΑΦΗ … · 62 57322 248400705 aranesp solution for injection 60mcg/0,3ml pf.syr./ btx4pf.syr with needle guard

Α/ΑΚΩ∆. ΑΡΧΕΙΟΥ

ΓΓΕ ΚΩ∆. ΕΟΦ ΟΝΟΜΑΣΙΑ ΚΩ∆. ΕΤ. ΠΕΡΙΓΡΑΦΗ ΕΤΑΙΡΕΙΑΣ Ν.3816 ΧΟΝ∆ΡΙΚΗ ΝΟΣΟΚΟΜΕΙΑΚΗ Ν.ΧΟΝ∆ΡΙΚΗ ΛΙΑΝΙΚΗ

376 56507 287230101NPLATE PD.INJ.SOL. 250MCG/VIAL BTx1VIAL

023 AMGEN EUROPE B.V. N 673,00 585,51 600,15 754,21

377 56508 287230201NPLATE PD.INJ.SOL. 500MCG/VIAL BTx1VIAL

023 AMGEN EUROPE B.V. N 1346,00 1171,02 1200,30 1508,42

378 55328 247280201NUTROPIN Aq INJ. SOL 10MG/2ML BT 1 CARTx2ML

712 IPSEN PHARMA FRANCE N 241,06 209,72 214,96 270,14

379 55329 247280202NUTROPIN Aq INJ. SOL 10MG/2ML BT 3 CARTx2ML

712 IPSEN PHARMA FRANCE N 801,51 697,31 714,74 898,21

380 53859 223020103 OCTAGAM SOL IV INF 5% FL 100ML 256 ΟΚΤΑΦΑΡΜΑ N 217,20 188,96 193,68 243,40

381 53860 223020104 OCTAGAM SOL IV INF 5% FL 200ML 256 ΟΚΤΑΦΑΡΜΑ N 348,11 302,86 310,43 390,12

382 53861 223020101 OCTAGAM SOL IV INF 5% FL 20ML 256 ΟΚΤΑΦΑΡΜΑ N 49,11 42,73 43,80 55,04

383 53862 223020102 OCTAGAM SOL IV INF 5% FL 50ML 256 ΟΚΤΑΦΑΡΜΑ N 91,82 79,88 81,88 102,90

384 41956 272000101ONCOTAXEN CS.SOL.INF 6MG/ML BTx1 (VIALx100MG) x17ML

327 SAMBROOK N 215,70 187,66 192,35 241,73

385 41957 272000102ONCOTAXEN CS.SOL.INF 6MG/ML BTx1 (VIALx300MG) x50ML

327 SAMBROOK N 623,68 542,60 556,17 698,94

386 55824 278010101ORENCIA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION BT 1VIALx250MG+1SY

461BRISTOL MYERS PHARMA EEIG

N 345,87 300,91 308,43 387,60

387 55563 267290102OVAPAC CS.SOL.INF 6MG/ML BTx1 VIAL (100MG/16,7ML)

639 ΦΑΡΜΑΤΕΝ ΕΛΛΑΣ ΑΕΒΕ N 215,71 187,67 192,36 241,74

388 55564 267290101OVAPAC CS.SOL.INF 6MG/ML BTx1 VIAL (30MG/5ML)

639 ΦΑΡΜΑΤΕΝ ΕΛΛΑΣ ΑΕΒΕ N 67,11 58,39 59,85 75,21

389 55565 267290103OVAPAC CS.SOL.INF 6MG/ML BTx10 VIAL (30MG/5ML)

639 ΦΑΡΜΑΤΕΝ ΕΛΛΑΣ ΑΕΒΕ N 671,22 583,96 598,56 752,21

390 56515 272190201OXALIPLATIN/HOSPIRA CS.SOL.INF 5MG/ML BTx1VIALx10ML

654 HOSPIRA UK LTD N 131,03 114,00 116,85 146,85

Page 26 of 46

Page 27: Κ ΑΡΧΕΙΟΥ Α Κ ΕΟΦ ΟΝΟΜΑΣΙΑ Κ ΕΤ ΠΕΡΙΓΡΑΦΗ … · 62 57322 248400705 aranesp solution for injection 60mcg/0,3ml pf.syr./ btx4pf.syr with needle guard

Α/ΑΚΩ∆. ΑΡΧΕΙΟΥ

ΓΓΕ ΚΩ∆. ΕΟΦ ΟΝΟΜΑΣΙΑ ΚΩ∆. ΕΤ. ΠΕΡΙΓΡΑΦΗ ΕΤΑΙΡΕΙΑΣ Ν.3816 ΧΟΝ∆ΡΙΚΗ ΝΟΣΟΚΟΜΕΙΑΚΗ Ν.ΧΟΝ∆ΡΙΚΗ ΛΙΑΝΙΚΗ

391 56516 272190202OXALIPLATIN/HOSPIRA CS.SOL.INF 5MG/ML BTx1VIALx20ML

654 HOSPIRA UK LTD N 251,32 218,65 224,12 281,65

392 55898 272190102OXALIPLATIN/HOSPIRA PD.SOL.INF 5MG/1ML BTx1VIALx100MG

654 HOSPIRA UK LTD N 251,32 218,65 224,12 281,65

393 55899 272190101OXALIPLATIN/HOSPIRA PD.SOL.INF 5MG/1ML BTx1VIALx50MG

654 HOSPIRA UK LTD N 131,03 114,00 116,85 146,85

394 57261 278770101OXALIPLATIN/KABI C/S.SOL.IN 5MG/ML VIALx10MLx50MG

706FRESENIUS KABI ONC. PLC UK

N 128,69 111,96 114,76 144,22

395 57262 278770102OXALIPLATIN/KABI C/S.SOL.IN 5MG/ML VIALx20MLx100MG

706FRESENIUS KABI ONC. PLC UK

N 257,39 223,93 229,53 288,45

396 42334 282370101OXALIPLATIN/MEDICUS CS.SOL.INF.5MG/1ML X 1VIAL X 10ML

223 MEDICUS ΑΕ N 131,03 114,00 116,85 146,85

397 42335 282370102OXALIPLATIN/MEDICUS CS.SOL.INF.5MG/1ML X 1VIAL X 20ML

223 MEDICUS ΑΕ N 257,39 223,93 229,53 288,45

398 42022 272650103OXALIPLATIN/TEVA CS. SOL.INF 5MG/ML BTx1 VIAL 100MG/20ML

644 TEVA PHARMA B.V. N 251,32 218,65 224,12 281,65

399 42023 272650101OXALIPLATIN/TEVA CS. SOL.INF 5MG/ML BTx1 VIAL 20MG/4ML

644 TEVA PHARMA B.V. N 58,70 51,07 52,35 65,79

400 42024 272650102OXALIPLATIN/TEVA CS. SOL.INF 5MG/ML BTx1 VIAL 50MG/10ML

644 TEVA PHARMA B.V. N 131,03 114,00 116,85 146,85

401 42025 272650203OXALIPLATIN/TEVA PD. SOL.INF 5MG/ML BTx1 VIALx100MG

644 TEVA PHARMA B.V. N 251,32 218,65 224,12 281,65

402 42026 272650201OXALIPLATIN/TEVA PD. SOL.INF 5MG/ML BTx1 VIALx20MG

644 TEVA PHARMA B.V. N 58,70 51,07 52,35 65,79

403 42027 272650202OXALIPLATIN/TEVA PD. SOL.INF 5MG/ML BTx1 VIALx50MG

644 TEVA PHARMA B.V. N 131,03 114,00 116,85 146,85

404 42212 281890101OXALIPROL CS.SOL.INF 5MG/1ML BTx1VIALx10ML

293 ΠPOEΛ AE N 131,03 114,00 116,85 146,85

405 42213 281890102OXALIPROL CS.SOL.INF 5MG/1ML BTx1VIALx20ML

293 ΠPOEΛ AE N 251,32 218,65 224,12 281,65

Page 27 of 46

Page 28: Κ ΑΡΧΕΙΟΥ Α Κ ΕΟΦ ΟΝΟΜΑΣΙΑ Κ ΕΤ ΠΕΡΙΓΡΑΦΗ … · 62 57322 248400705 aranesp solution for injection 60mcg/0,3ml pf.syr./ btx4pf.syr with needle guard

Α/ΑΚΩ∆. ΑΡΧΕΙΟΥ

ΓΓΕ ΚΩ∆. ΕΟΦ ΟΝΟΜΑΣΙΑ ΚΩ∆. ΕΤ. ΠΕΡΙΓΡΑΦΗ ΕΤΑΙΡΕΙΑΣ Ν.3816 ΧΟΝ∆ΡΙΚΗ ΝΟΣΟΚΟΜΕΙΑΚΗ Ν.ΧΟΝ∆ΡΙΚΗ ΛΙΑΝΙΚΗ

406 42214 281890103OXALIPROL CS.SOL.INF 5MG/1ML BTx1VIALx40ML

293 ΠPOEΛ AE N 461,23 401,27 411,30 516,88

407 57263 281730102PACLITAXEL KABI C/S.SOL.IN 6MG/ML BTx1VIALx16,7ML

393FRESENIUS KABI HELLAS AE

N 194,14 168,90 173,12 217,56

408 57264 281730101PACLITAXEL KABI C/S.SOL.IN 6MG/ML BTx1VIALx5ML

393FRESENIUS KABI HELLAS AE

N 60,41 52,56 53,87 67,70

409 57265 281730105PACLITAXEL KABI C/S.SOL.IN 6MG/ML BTx5VIALSx16,7ML

393FRESENIUS KABI HELLAS AE

N 970,70 844,51 865,62 1087,82

410 57266 281730106PACLITAXEL KABI C/S.SOL.IN 6MG/ML BTx5VIALSX50ML

393FRESENIUS KABI HELLAS AE

N 2806,62 2441,76 2502,80 3145,27

411 57267 281730104PACLITAXEL KABI C/S.SOL.IN 6MG/ML BTx5VIALSx5ML

393FRESENIUS KABI HELLAS AE

N 302,05 262,78 269,35 338,49

412 57268 281730103PACLITAXEL KABI C/S.SOL.IN 6MG/ML C/S.SOL.IN 6MG/ML BTx1VIALx50ML

393FRESENIUS KABI HELLAS AE

N 561,32 488,35 500,56 629,05

413 55901 275010102PACLITAXEL/GENERICS CS.SOL.INF. 6MG/ML BTx 1VIALx16,7ML (100MG/16,7ML)

351GENERICS PHAR.HELLAS ΕΠΕ

N 215,71 187,67 192,36 241,74

414 55902 275010101PACLITAXEL/GENERICS CS.SOL.INF. 6MG/ML BTx 1VIALx5ML (30MG/5ML)

351GENERICS PHAR.HELLAS ΕΠΕ

N 67,11 58,39 59,85 75,21

415 55337 266380102PACLITAXEL/HOSPIRA CS.SOL.INF. BTx1VIALx16,7MLx6MG/ML

654 HOSPIRA UK LTD N 215,71 187,67 192,36 241,74

416 55338 266380103PACLITAXEL/HOSPIRA CS.SOL.INF. BTx1VIALx25MLx6MG/ML

654 HOSPIRA UK LTD N 335,63 292,00 299,30 376,13

417 55339 266380104PACLITAXEL/HOSPIRA CS.SOL.INF. BTx1VIALx50MLx6MG/ML

654 HOSPIRA UK LTD N 623,69 542,61 556,18 698,95

418 55340 266380101PACLITAXEL/HOSPIRA CS.SOL.INF. BTx1VIALx5MLx6MG/ML

654 HOSPIRA UK LTD N 67,11 58,39 59,85 75,21

419 55344 263360402PACLITOL CS.SOL.INF. BTx1VIAL 100MG/16,7ML (MULTIDOSE)

388 ΦΑΡΜΑΝΕΛ ΦΑΡΜ/ΚΗ ΑΕ N 215,71 187,67 192,36 241,74

420 55345 263360403PACLITOL CS.SOL.INF. BTx1VIAL 300MG/50ML (MULTIDOSE)

388 ΦΑΡΜΑΝΕΛ ΦΑΡΜ/ΚΗ ΑΕ N 623,69 542,61 556,18 698,95

Page 28 of 46

Page 29: Κ ΑΡΧΕΙΟΥ Α Κ ΕΟΦ ΟΝΟΜΑΣΙΑ Κ ΕΤ ΠΕΡΙΓΡΑΦΗ … · 62 57322 248400705 aranesp solution for injection 60mcg/0,3ml pf.syr./ btx4pf.syr with needle guard

Α/ΑΚΩ∆. ΑΡΧΕΙΟΥ

ΓΓΕ ΚΩ∆. ΕΟΦ ΟΝΟΜΑΣΙΑ ΚΩ∆. ΕΤ. ΠΕΡΙΓΡΑΦΗ ΕΤΑΙΡΕΙΑΣ Ν.3816 ΧΟΝ∆ΡΙΚΗ ΝΟΣΟΚΟΜΕΙΑΚΗ Ν.ΧΟΝ∆ΡΙΚΗ ΛΙΑΝΙΚΗ

421 55346 263360401PACLITOL CS.SOL.INF. BTx1VIAL 30MG/5ML (MONODOSE)

388 ΦΑΡΜΑΝΕΛ ΦΑΡΜ/ΚΗ ΑΕ N 67,11 58,39 59,85 75,21

422 41587 263810302PACLIXEL CS.SOL.INF 6MG/ML BTx1 VIAL (100MG)X16,7ML

446NOVAGEN PHARMACEUTICALS

N 215,71 187,67 192,36 241,74

423 41588 263810301PACLIXEL CS.SOL.INF 6MG/ML BTx1 VIAL (30MG)X5ML

446NOVAGEN PHARMACEUTICALS

N 67,11 58,39 59,85 75,21

424 54523 245460101 PANRETIN GEL 0,1% TB 60G 350 GALENICA AE N 1421,44 1236,65 1267,57 1592,96

425 12190 263870102PATAXEL BTx1VIAL (100MG) x 16,7ML (MULTIDOSE)

040 BIANEΞ AE N 215,71 187,67 192,36 241,74

426 12191 263870103PATAXEL BTx1VIAL (300MG) x 50ML (MULTIDOSE)

040 BIANEΞ AE N 623,69 542,61 556,18 698,95

427 12192 263870101PATAXEL BTx1VIAL (30MG) x 5ML (MONODOSE)

040 BIANEΞ AE N 67,11 58,39 59,85 75,21

428 55052 248360301 PAXENE CS.SOL.NF 1VIAL 17MLx6MG/ML 060 ΓEPOΛYMATOΣ Π.N ΑΕΒΕ N 215,71 187,67 192,36 241,74

429 55053 248360401 PAXENE CS.SOL.NF 1VIAL 50MLx6MG/ML 060 ΓEPOΛYMATOΣ Π.N ΑΕΒΕ N 623,69 542,61 556,18 698,95

430 56011 277400104PAXENE PACLITAXEL CS.SOL.INF 6MG/ML BTx1VIALx25ML

608PHARMACHEMIE B.V. HOLLAND

N 335,63 292,00 299,30 376,13

431 55341 277400102PAXENE PACLITAXEL CS.SOL.INF. 6MG/ML BTx1VIALx16,7ML

608PHARMACHEMIE B.V. HOLLAND

N 215,71 187,67 192,36 241,74

432 55342 277400103PAXENE PACLITAXEL CS.SOL.INF. 6MG/ML BTx1VIALx50ML

608PHARMACHEMIE B.V. HOLLAND

N 623,69 542,61 556,18 698,95

433 55343 277400101PAXENE PACLITAXEL CS.SOL.INF. 6MG/ML BTx1VIALx5ML

608PHARMACHEMIE B.V. HOLLAND

N 67,11 58,39 59,85 75,21

434 14032 277490103PAXITAL CS.SOL.INF 6MG/ML BTx1VIAL (150MG) x25ML (MULTIDOSE)

590 MEDICAMERC AE N 335,62 291,99 299,29 376,12

435 14033 277490104PAXITAL CS.SOL.INF 6MG/ML BTx1VIAL (300MG) x50ML (MULTIDOSE)

590 MEDICAMERC AE N 623,68 542,60 556,17 698,94

Page 29 of 46

Page 30: Κ ΑΡΧΕΙΟΥ Α Κ ΕΟΦ ΟΝΟΜΑΣΙΑ Κ ΕΤ ΠΕΡΙΓΡΑΦΗ … · 62 57322 248400705 aranesp solution for injection 60mcg/0,3ml pf.syr./ btx4pf.syr with needle guard

Α/ΑΚΩ∆. ΑΡΧΕΙΟΥ

ΓΓΕ ΚΩ∆. ΕΟΦ ΟΝΟΜΑΣΙΑ ΚΩ∆. ΕΤ. ΠΕΡΙΓΡΑΦΗ ΕΤΑΙΡΕΙΑΣ Ν.3816 ΧΟΝ∆ΡΙΚΗ ΝΟΣΟΚΟΜΕΙΑΚΗ Ν.ΧΟΝ∆ΡΙΚΗ ΛΙΑΝΙΚΗ

436 12270 277490101PAXITAL CS.SOL.INF. 6MG/ML BTx1VIAL(30MG)x5ML (MONODOSE)

590 MEDICAMERC AE N 67,11 58,39 59,85 75,21

437 12269 277490102PAXITAL CS.SOL.INF. 6MG/ML BTx1VIAL(100MG)x16,7ML (MULTIDOSE)

590 MEDICAMERC AE N 215,70 187,66 192,35 241,73

438 54647 251730301PEGASΥS INJ.SOL.PF.SYR 1x135MCG/0,5ML

315 ROCHE EΛΛAΣ ΑΕ N 148,99 129,62 132,86 166,97

439 54648 251730401PEGASΥS INJ.SOL.PF.SYR 1x180MCG/0,5ML

315 ROCHE EΛΛAΣ ΑΕ N 172,66 150,21 153,97 193,49

440 54649 251730302PEGASΥS INJ.SOL.PF.SYR 4x135MCG/0,5ML

315 ROCHE EΛΛAΣ ΑΕ N 584,67 508,66 521,38 655,22

441 54650 251730402PEGASΥS INJ.SOL.PF.SYR 4x180MCG/0,5ML

315 ROCHE EΛΛAΣ ΑΕ N 677,68 589,58 604,32 759,45

442 54750 245740801 PEGINTRON PS INJ PREFILL PEN 100MCG 476 SP.EUROPE N 170,57 148,40 152,11 191,16

443 54751 245740901 PEGINTRON PS INJ PREFILL PEN 120MCG 476 SP.EUROPE N 204,66 178,05 182,50 229,35

444 54752 245741001 PEGINTRON PS INJ PREFILL PEN 150MCG 476 SP.EUROPE N 260,80 226,90 232,57 292,27

445 54753 245740601 PEGINTRON PS INJ PREFILL PEN 50MCG 476 SP.EUROPE N 85,30 74,21 76,07 95,60

446 54754 245740701 PEGINTRON PS INJ PREFILL PEN 80MCG 476 SP.EUROPE N 135,90 118,23 121,19 152,30

447 54325 245740301PEGINTRON PS INJ SOL 1 VIALx100MCG+SOLV 0,5ML

476 SP.EUROPE N 170,57 148,40 152,11 191,16

448 54326 245740401PEGINTRON PS INJ SOL 1 VIALx120MCG+SOLV 0,5ML

476 SP.EUROPE N 162,89 141,71 145,25 182,54

449 54327 245740501PEGINTRON PS INJ SOL 1 VIALx150MCG+SOLV 0,5ML

476 SP.EUROPE N 247,01 214,90 220,27 276,81

450 54328 245740201PEGINTRON PS INJ SOL 1 VIALx80MCG+SOLV 0,5ML

476 SP.EUROPE N 108,51 94,40 96,76 121,60

Page 30 of 46

Page 31: Κ ΑΡΧΕΙΟΥ Α Κ ΕΟΦ ΟΝΟΜΑΣΙΑ Κ ΕΤ ΠΕΡΙΓΡΑΦΗ … · 62 57322 248400705 aranesp solution for injection 60mcg/0,3ml pf.syr./ btx4pf.syr with needle guard

Α/ΑΚΩ∆. ΑΡΧΕΙΟΥ

ΓΓΕ ΚΩ∆. ΕΟΦ ΟΝΟΜΑΣΙΑ ΚΩ∆. ΕΤ. ΠΕΡΙΓΡΑΦΗ ΕΤΑΙΡΕΙΑΣ Ν.3816 ΧΟΝ∆ΡΙΚΗ ΝΟΣΟΚΟΜΕΙΑΚΗ Ν.ΧΟΝ∆ΡΙΚΗ ΛΙΑΝΙΚΗ

451 54046 245740101PEGINTRON PS INJ SOL 1VIALx50MCG+SOLV

476 SP.EUROPE N 69,74 60,67 62,19 78,15

452 54443 240120101PENTAGLOBIN SOL.IV.INF 50MG/ML 1AMPx10ML

212 BIOTEST ΕΛΛΑΣ Μ.Ε.Π.Ε. N 43,10 37,50 38,44 48,31

453 54444 240120102PENTAGLOBIN SOL.IV.INF 50MG/ML 1AMPx20ML

212 BIOTEST ΕΛΛΑΣ Μ.Ε.Π.Ε. N 81,13 70,58 72,34 90,91

454 54445 240120104PENTAGLOBIN SOL.IV.INF 50MG/ML 1BOTTLEx100ML

212 BIOTEST ΕΛΛΑΣ Μ.Ε.Π.Ε. N 350,80 305,20 312,83 393,13

455 54446 240120103PENTAGLOBIN SOL.IV.INF 50MG/ML 1BOTTLEx50ML

212 BIOTEST ΕΛΛΑΣ Μ.Ε.Π.Ε. N 177,36 154,30 158,16 198,76

456 57624 297220102PEYONA, SO.INF.ORA 20MG/ML, BT X10AMP X 1ML

732CHIESI FARMACEUTICI SPA

N 240,87 209,56 214,80 269,94

457 54525 239530101 PHOTOFRIN PD.INJ.SOL 1VIALx15MG 350 GALENICA AE N 189,91 165,22 169,35 212,82

458 54526 239530201 PHOTOFRIN PD.INJ.SOL 1VIALx75MG 350 GALENICA AE N 949,53 826,09 846,74 1064,10

459 56177 278700102PLAXITIN PD.SOL.INF 5MG/ML BTx1VIAL(100MG/VIAL)

564 EBEWE PHARMA GMBH N 251,32 218,65 224,12 281,65

460 56178 278700103PLAXITIN PD.SOL.INF 5MG/ML BTx1VIAL(150MG/VIAL)

564 EBEWE PHARMA GMBH N 333,00 289,71 296,95 373,18

461 56179 278700101PLAXITIN PD.SOL.INF 5MG/ML BTx1VIAL(50MG/VIAL)

564 EBEWE PHARMA GMBH N 131,03 114,00 116,85 146,85

462 56276 283730101PRIALT SOL.INF. 100MCG/ML BTx1VIALx1ML

633 EISAI LTD N 370,03 321,93 329,98 414,69

463 56277 283730103PRIALT SOL.INF. 100MCG/ML BTx1VIALx5ML

633 EISAI LTD N 1850,15 1609,63 1649,87 2073,39

464 56421 283690102PRIVIGEN SOL.IV.INF 100MG/ML BTx1VIALx100ML

660 CSL BEHRING GMBH N 451,72 393,00 402,83 506,24

465 56422 283690103PRIVIGEN SOL.IV.INF 100MG/ML BTx1VIALx200ML

660 CSL BEHRING GMBH N 903,44 785,99 805,64 1012,45

Page 31 of 46

Page 32: Κ ΑΡΧΕΙΟΥ Α Κ ΕΟΦ ΟΝΟΜΑΣΙΑ Κ ΕΤ ΠΕΡΙΓΡΑΦΗ … · 62 57322 248400705 aranesp solution for injection 60mcg/0,3ml pf.syr./ btx4pf.syr with needle guard

Α/ΑΚΩ∆. ΑΡΧΕΙΟΥ

ΓΓΕ ΚΩ∆. ΕΟΦ ΟΝΟΜΑΣΙΑ ΚΩ∆. ΕΤ. ΠΕΡΙΓΡΑΦΗ ΕΤΑΙΡΕΙΑΣ Ν.3816 ΧΟΝ∆ΡΙΚΗ ΝΟΣΟΚΟΜΕΙΑΚΗ Ν.ΧΟΝ∆ΡΙΚΗ ΛΙΑΝΙΚΗ

466 56423 283690101PRIVIGEN SOL.IV.INF 100MG/ML BTx1VIALx50ML

660 CSL BEHRING GMBH N 225,86 196,50 201,41 253,11

467 41111 239320101PROGRAF CAPS 30(BLIST 3x10 SACHETS AL)x1MG

440ASTELLAS PHARM/CALS AEBE

N 50,94 44,32 45,43 57,09

468 41112 239320201PROGRAF CAPS 30(BLIST 3x10 SACHETS AL)x5MG

440ASTELLAS PHARM/CALS AEBE

N 242,89 211,31 216,59 272,19

469 41353 239320401 PROGRAF CAPS BT 30x0,5MG 440ASTELLAS PHARM/CALS AEBE

N 27,32 23,77 24,36 30,61

470 53672 239320301 PROGRAF CS.SOL.INF 10AMPx5MG/1ML 440ASTELLAS PHARM/CALS AEBE

N 392,15 341,17 349,70 439,47

471 52390 221320101PULMOZYME SOL INH FL 6x2500U/2,5ML (1 DOSE AMP)

315 ROCHE EΛΛAΣ ΑΕ N 119,11 103,63 106,22 133,49

472 54657 252080501 RAPAMUNE F.C.TABL BT 30x1MG 295 PFIZER HELLAS ΑΕ N 115,57 100,55 103,06 129,52

473 54345 252080102 RAPAMUNE ORAL SOL FL 150MLx1MG/ML 408 WYETH EΛΛΑΣ ΑΕΒΕ N 431,01 374,98 384,35 483,01

474 54346 252080101 RAPAMUNE ORAL SOL FL 60MLx1MG/ML 295 PFIZER HELLAS ΑΕ N 172,40 149,99 153,74 193,21

475 54347 252080201 RAPAMUNE SACHETS 30x1MG/ML 408 WYETH EΛΛΑΣ ΑΕΒΕ N 86,20 74,99 76,86 96,59

476 54348 252080301 RAPAMUNE SACHETS 30x2MG/2ML 408 WYETH EΛΛΑΣ ΑΕΒΕ N 172,40 149,99 153,74 193,21

477 54349 252080401 RAPAMUNE SACHETS 30x5MG/5ML 408 WYETH EΛΛΑΣ ΑΕΒΕ N 431,01 374,98 384,35 483,01

478 53539 228550101RAPILYSIN LY.PD.INJ 10IU/VIAL 2VIALx1.16G+2PF.SYRx10ML SOLV + APP.REC

605 ACTAVIS GROUP PTC EHF N 826,44 719,00 736,98 926,16

479 53737 245150102 REBETOL CAPS 140x200MG 476 SP.EUROPE N 404,99 352,34 361,15 453,86

480 53738 245150103 REBETOL CAPS 168x200MG 476 SP.EUROPE N 486,00 422,82 433,39 544,64

Page 32 of 46

Page 33: Κ ΑΡΧΕΙΟΥ Α Κ ΕΟΦ ΟΝΟΜΑΣΙΑ Κ ΕΤ ΠΕΡΙΓΡΑΦΗ … · 62 57322 248400705 aranesp solution for injection 60mcg/0,3ml pf.syr./ btx4pf.syr with needle guard

Α/ΑΚΩ∆. ΑΡΧΕΙΟΥ

ΓΓΕ ΚΩ∆. ΕΟΦ ΟΝΟΜΑΣΙΑ ΚΩ∆. ΕΤ. ΠΕΡΙΓΡΑΦΗ ΕΤΑΙΡΕΙΑΣ Ν.3816 ΧΟΝ∆ΡΙΚΗ ΝΟΣΟΚΟΜΕΙΑΚΗ Ν.ΧΟΝ∆ΡΙΚΗ ΛΙΑΝΙΚΗ

481 53739 245150101 REBETOL CAPS 84x200MG 476 SP.EUROPE N 242,99 211,40 216,69 272,31

482 55573 245150201 REBETOL ORAL.SOL. 40MG/ML FLx100ML 476 SP.EUROPE N 56,52 49,17 50,40 63,34

483 56606 233241101REBIF INJ.SOL 132MCG (44MCG/0,5ML)/1,5ML BTx4 CARTRIDGES

483SERONO (EUROPE) LTD UK

N 955,77 831,52 852,31 1071,10

484 56607 233241001REBIF INJ.SOL 66MCG (22MCG/0,5ML)/1,5ML BTx4 CARTRIDGES

483SERONO (EUROPE) LTD UK

N 827,64 720,05 738,05 927,51

485 53540 233240603REBIF-22MCG(6MIU) INJ SOL 12PF.SYRx0.5ML

326 SERONO HELLAS ΑΕ N 792,95 689,87 707,12 888,64

486 53541 233240601REBIF-22MCG(6MIU) INJ SOL 1PF.SYRx0.5ML

326 SERONO HELLAS ΑΕ N 51,98 45,22 46,35 58,25

487 53542 233240602REBIF-22MCG(6MIU) INJ SOL 3PF.SYRx0.5ML

326 SERONO HELLAS ΑΕ N 198,17 172,41 176,72 222,08

488 54186 233240801REBIF-44 MCG(12 MIU) INJ SOL 1 PF SYRx1ML

326 SERONO HELLAS ΑΕ N 70,29 61,15 62,68 78,77

489 54187 233240803REBIF-44 MCG(12 MIU) INJ SOL 12 PF SYRx1ML

326 SERONO HELLAS ΑΕ N 909,76 791,49 811,28 1019,54

490 54188 233240802REBIF-44 MCG(12 MIU) INJ SOL 3 PF SYRx1ML

326 SERONO HELLAS ΑΕ N 227,48 197,91 202,86 254,93

491 53882 248450101 REMICADE PD.SOL.INF 1FLx100MG/20ML 109SCHERING PLOUGH AΦBEE

N 543,92 473,21 485,04 609,55

492 55574 268890401REMODULIN SOL.INF 10MG/ML BTx1VIALx20ML

442 FERRER-GALENICA A.E. N 22662,86 19716,69 20209,61 25397,42

493 55575 268890101REMODULIN SOL.INF 1MG/ML BTx1VIALx20ML

442 FERRER-GALENICA A.E. N 2844,97 2475,12 2537,00 3188,25

494 55576 268890201REMODULIN SOL.INF 2,5MG/ML BTx1VIALx20ML

442 FERRER-GALENICA A.E. N 6483,79 5640,90 5781,92 7266,14

495 55577 268890301REMODULIN SOL.INF 5MG/ML BTx1VIALx20ML

442 FERRER-GALENICA A.E. N 11335,28 9861,69 10108,23 12703,01

Page 33 of 46

Page 34: Κ ΑΡΧΕΙΟΥ Α Κ ΕΟΦ ΟΝΟΜΑΣΙΑ Κ ΕΤ ΠΕΡΙΓΡΑΦΗ … · 62 57322 248400705 aranesp solution for injection 60mcg/0,3ml pf.syr./ btx4pf.syr with needle guard

Α/ΑΚΩ∆. ΑΡΧΕΙΟΥ

ΓΓΕ ΚΩ∆. ΕΟΦ ΟΝΟΜΑΣΙΑ ΚΩ∆. ΕΤ. ΠΕΡΙΓΡΑΦΗ ΕΤΑΙΡΕΙΑΣ Ν.3816 ΧΟΝ∆ΡΙΚΗ ΝΟΣΟΚΟΜΕΙΑΚΗ Ν.ΧΟΝ∆ΡΙΚΗ ΛΙΑΝΙΚΗ

496 54540 250090101REPLAGAL CS.SOL INF. 1VIAL 3,5MLx1MG/ML

361 TKT N 1814,09 1578,26 1617,72 2032,99

497 56101 281510802RETACRIT INJ.SOL. 10000IU/1,0ML PF.SYR BTx6 PF.SYRSx1,0ML

654 HOSPIRA UK LTD N 388,57 338,06 346,51 435,46

498 56102 281510102RETACRIT INJ.SOL. 1000IU/0,3ML PF.SYR BTx6 PF.SYRSx0,3ML

654 HOSPIRA UK LTD N 42,53 37,00 37,93 47,67

499 56103 281510202RETACRIT INJ.SOL. 2000IU/0,6ML PF.SYR BTx6 PF.SYRSx0,6ML

654 HOSPIRA UK LTD N 78,90 68,64 70,36 88,42

500 56104 281510302RETACRIT INJ.SOL. 3000IU/0,9ML PF.SYR BTx6 PF.SYRSx0,9ML

654 HOSPIRA UK LTD N 118,36 102,97 105,54 132,63

501 56105 281511101RETACRIT INJ.SOL. 40000IU/1,0ML PF.SYR BTx1 PF.SYRx1,0ML

654 HOSPIRA UK LTD N 303,60 264,13 270,73 340,23

502 56528 281511102RETACRIT INJ.SOL. 40000IU/1,0ML PF.SYR BTx4 PF.SYRSx1,0ML

654 HOSPIRA UK LTD N 1214,43 1056,55 1082,96 1360,96

503 56106 281510402RETACRIT INJ.SOL. 4000IU/0,4ML PF.SYR BTx6 PF.SYRSx0,4ML

654 HOSPIRA UK LTD N 157,82 137,30 140,73 176,86

504 56107 281510502RETACRIT INJ.SOL. 5000IU/0,5ML PF.SYR BTx6 PF.SYRSx0,5ML

654 HOSPIRA UK LTD N 197,26 171,62 175,91 221,07

505 56108 281510602RETACRIT INJ.SOL. 6000IU/0,6ML PF.SYR BTx6 PF.SYRSx0,6ML

654 HOSPIRA UK LTD N 236,72 205,95 211,10 265,29

506 56109 281510702RETACRIT INJ.SOL. 8000IU/0,8ML PF.SYR BTx6 PF.SYRSx0,8ML

654 HOSPIRA UK LTD N 330,38 287,43 294,62 370,25

507 56191 270460101 REVATIO F.C. TABL 20MG/TAB BTx90 470 PFIZER LTD, UK N 469,26 408,26 418,47 525,89

508 55910 278110201REVLIMID HARD CAPS 10MG/CAP BTx21 σε BLISTERS (PCTFE/PVC/ALU)

567 CELGENE EUROPE LTD N 5411,74 4708,21 4825,92 6064,73

509 55911 278110301REVLIMID HARD CAPS 15MG/CAP BTx21 σε BLISTERS (PCTFE/PVC/ALU)

567 CELGENE EUROPE LTD N 5695,47 4955,06 5078,94 6382,70

510 55912 278110401REVLIMID HARD CAPS 25MG/CAP BTx21 σε BLISTERS (PCTFE/PVC/ALU)

567 CELGENE EUROPE LTD N 6258,36 5444,77 5580,89 7013,50

Page 34 of 46

Page 35: Κ ΑΡΧΕΙΟΥ Α Κ ΕΟΦ ΟΝΟΜΑΣΙΑ Κ ΕΤ ΠΕΡΙΓΡΑΦΗ … · 62 57322 248400705 aranesp solution for injection 60mcg/0,3ml pf.syr./ btx4pf.syr with needle guard

Α/ΑΚΩ∆. ΑΡΧΕΙΟΥ

ΓΓΕ ΚΩ∆. ΕΟΦ ΟΝΟΜΑΣΙΑ ΚΩ∆. ΕΤ. ΠΕΡΙΓΡΑΦΗ ΕΤΑΙΡΕΙΑΣ Ν.3816 ΧΟΝ∆ΡΙΚΗ ΝΟΣΟΚΟΜΕΙΑΚΗ Ν.ΧΟΝ∆ΡΙΚΗ ΛΙΑΝΙΚΗ

511 55913 278110101REVLIMID HARD CAPS 5MG/CAP BTx21 σε BLISTERS (PCTFE/PVC/ALU)

567 CELGENE EUROPE LTD N 4802,71 4178,36 4282,82 5382,22

512 57028 293500102REVOLADE FC. TAB 25 MG/TAB BTx28 σε BLIST (PA/ALU/PVC/ALU)

411 GLAXO SMITHKLINΕ AEBE N 1078,64 938,42 961,88 1208,79

513 57029 293500202REVOLADE FC. TAB 50 MG/TAB BTx28 σε BLIST (PA/ALU/PVC/ALU)

411 GLAXO SMITHKLINΕ AEBE N 2157,32 1876,87 1923,79 2417,63

514 57030 291900104RIBAVIRIN/TEVA CAPS 200 MG/CAP, BT x 168 (BLISTERS PVC/PE/PVdC)

644 TEVA PHARMA B.V. N 437,39 380,53 390,04 490,16

515 57673 291890106RIBAVIRIN/TEVA FC.TAB 200MG/TAB BTx112 (BLISTERS PVC/PE/PVAc)

644 TEVA PHARMA B.V N 257,90 224,37 229,98 289,02

516 57032 291890108RIBAVIRIN/TEVA PHARMA BV FC.TAB 200 MG/TAB, BT x 168 (BLISTERS PVC/PE/PVAc)

644 TEVA PHARMA B.V. N 462,66 402,51 412,57 518,48

517 53190 228120101 RILUTEK F.C.TABL 56x50MG 316 AVENTIS PHARMA ΑΒΕE N 216,28 188,16 192,86 242,37

518 56529 287160103RoACTEMRA CS.SOL.INF 20MG/ML BTx1VIALx10ML

487ROCHE REGISTRATION LTD,UK

N 341,33 296,96 304,38 382,51

519 56530 287160105RoACTEMRA CS.SOL.INF 20MG/ML BTx1VIALx20ML

487ROCHE REGISTRATION LTD,UK

N 654,16 569,12 583,35 733,10

520 56531 287160101RoACTEMRA CS.SOL.INF 20MG/ML BTx1VIALx4ML

487ROCHE REGISTRATION LTD,UK

N 137,63 119,74 122,73 154,23

521 56532 287160104RoACTEMRA CS.SOL.INF 20MG/ML BTx4VIALSx10ML

487ROCHE REGISTRATION LTD,UK

N 1365,31 1187,82 1217,52 1530,06

522 56533 287160106RoACTEMRA CS.SOL.INF 20MG/ML BTx4VIALSx20ML

487ROCHE REGISTRATION LTD,UK

N 2354,05 2048,02 2099,22 2638,09

523 56534 287160102RoACTEMRA CS.SOL.INF 20MG/ML BTx4VIALSx4ML

487ROCHE REGISTRATION LTD,UK

N 565,85 492,29 504,60 634,13

524 54057 193421201ROFERON-A INJ SOL 3MIU 1PF.SYR.x0,5ML

315 ROCHE EΛΛAΣ ΑΕ N 15,62 13,59 13,93 17,51

525 54058 193421203ROFERON-A INJ SOL 3MIU 6PF.SYR.x0,5ML

315 ROCHE EΛΛAΣ ΑΕ N 93,74 81,55 83,59 105,05

Page 35 of 46

Page 36: Κ ΑΡΧΕΙΟΥ Α Κ ΕΟΦ ΟΝΟΜΑΣΙΑ Κ ΕΤ ΠΕΡΙΓΡΑΦΗ … · 62 57322 248400705 aranesp solution for injection 60mcg/0,3ml pf.syr./ btx4pf.syr with needle guard

Α/ΑΚΩ∆. ΑΡΧΕΙΟΥ

ΓΓΕ ΚΩ∆. ΕΟΦ ΟΝΟΜΑΣΙΑ ΚΩ∆. ΕΤ. ΠΕΡΙΓΡΑΦΗ ΕΤΑΙΡΕΙΑΣ Ν.3816 ΧΟΝ∆ΡΙΚΗ ΝΟΣΟΚΟΜΕΙΑΚΗ Ν.ΧΟΝ∆ΡΙΚΗ ΛΙΑΝΙΚΗ

526 54059 193421301ROFERON-A INJ SOL 4.5MIU 1PF.SYR.x0,5ML

315 ROCHE EΛΛAΣ ΑΕ N 22,03 19,17 19,65 24,69

527 54060 193421303ROFERON-A INJ SOL 4.5MIU 6PF.SYR.x0,5ML

315 ROCHE EΛΛAΣ ΑΕ N 132,15 114,97 117,84 148,09

528 54061 193421401ROFERON-A INJ SOL 6MIU 1PF.SYR.x0,5ML

315 ROCHE EΛΛAΣ ΑΕ N 28,85 25,10 25,73 32,33

529 54062 193421403ROFERON-A INJ SOL 6MIU 6PF.SYR.x0,5ML

315 ROCHE EΛΛAΣ ΑΕ N 192,97 167,88 172,08 216,25

530 54063 193421501ROFERON-A INJ SOL 9MIU 1PF.SYR.x0,5ML

315 ROCHE EΛΛAΣ ΑΕ N 45,39 39,49 40,48 50,87

531 54064 193421503ROFERON-A INJ SOL 9MIU 6PF.SYR.x0,5ML

315 ROCHE EΛΛAΣ ΑΕ N 198,01 172,27 176,58 221,91

532 50874 186110301SANDOGLOBULIN INJ LYOPH FL 6GR+SOLV 200ML IV

438 CSL BEHRING Μ.ΕΠΕ N 231,09 201,05 206,08 258,98

533 50873 186110201SANDOGLOBULIN INJ LYOPH. FL 3GR+SOLV 100ML IV

438 CSL BEHRING Μ.ΕΠΕ N 115,97 100,89 103,41 129,96

534 41756 225670401SANDOSTATIN LAR PS.INJ.SUS 10MG/VIAL BTx1VIAL +1PF.SYRx2,5ML SOLV+2 βελόνες

321 NOVARTIS HELLAS AEΒΕ N 550,61 479,03 491,01 617,05

535 41757 225670501SANDOSTATIN LAR PS.INJ.SUS 20MG/VIAL BTx1VIAL +1PF.SYRx2,5ML SOLV+2 βελόνες

321 NOVARTIS HELLAS AEΒΕ N 880,75 766,25 785,41 987,02

536 41758 225670601SANDOSTATIN LAR PS.INJ.SUS 30MG/VIAL BTx1VIAL +1PF.SYRx2,5ML SOLV+2 βελόνες

321 NOVARTIS HELLAS AEΒΕ N 1142,76 994,20 1019,06 1280,65

537 42215 283400101SANTACIL CS.SOL INF 20MG/ML BTx1VIALx2MLx40MG

457 SANTA PHARMA AE N 51,67 44,95 46,07 57,90

538 42216 283400102SANTACIL CS.SOL INF 20MG/ML BTx1VIALx5ΜLx100MG

457 SANTA PHARMA AE N 129,16 112,37 115,18 144,75

539 42524 283400103SANTACIL, CS.SOL.INF. 20MG/ML, BT x 10 VIALS x 2ML x 40MG

457 SANTA PHARMA AE N 465,03 404,58 414,69 521,14

540 42525 283400104SANTACIL, CS.SOL.INF. 20MG/ML, BT x 10 VIALS x 5ML x 100MG

457 SANTA PHARMA AE N 1162,44 1011,32 1036,60 1302,70

Page 36 of 46

Page 37: Κ ΑΡΧΕΙΟΥ Α Κ ΕΟΦ ΟΝΟΜΑΣΙΑ Κ ΕΤ ΠΕΡΙΓΡΑΦΗ … · 62 57322 248400705 aranesp solution for injection 60mcg/0,3ml pf.syr./ btx4pf.syr with needle guard

Α/ΑΚΩ∆. ΑΡΧΕΙΟΥ

ΓΓΕ ΚΩ∆. ΕΟΦ ΟΝΟΜΑΣΙΑ ΚΩ∆. ΕΤ. ΠΕΡΙΓΡΑΦΗ ΕΤΑΙΡΕΙΑΣ Ν.3816 ΧΟΝ∆ΡΙΚΗ ΝΟΣΟΚΟΜΕΙΑΚΗ Ν.ΧΟΝ∆ΡΙΚΗ ΛΙΑΝΙΚΗ

541 55646 275000101SAVENE PCS.SOL.INF 500MG/VIAL (20MG/ML) BTx10 VIALS+3 ΣΑΚΟΙ X500ML SOLV

527 TOPO TARGET A/S N 10375,00 9026,25 9251,91 11626,88

542 55829 278170101SEBIVO F.C.TAB 600MG/TAB BTx28 σε BLISTER (PVC/ALU)

517NOVARTIS EUROPHARM LTD

N 355,41 309,21 316,94 398,30

543 56022 280140101SIKLOS F.C. TAB 1000MG/TAB BTx30 σε BLISTERS (PVC/PVDC/ALU)

610 ADDMEDICA N 731,90 636,75 652,67 820,21

544 57054 291650101SIMPONI IN.SO.PFP 50MG/0,5ML BTx1 PF PENx0,5ML

701 CENTOCOR B.V. N 1308,47 1138,37 1166,83 1466,36

545 57055 291650201SIMPONI IN.SO.PFS 50MG/0,5ML BTx1 PF SYRx0,5ML

701 CENTOCOR B.V. N 1308,47 1138,37 1166,83 1466,36

546 53565 238840101SIMULECT PS.INJ.SOL 1VIALx20MG+1SYR SOLV

321 NOVARTIS HELLAS AEΒΕ N 1015,26 883,28 905,36 1137,77

547 54931 224670501SOMATULINE AUTO GEL INJ.SOL 1 PF SYRx120MG

136 IPSEN EΠE N 1097,64 954,95 978,82 1230,08

548 54932 224670301SOMATULINE AUTO GEL INJ.SOL 1 PF SYRx60MG

136 IPSEN EΠE N 697,90 607,17 622,35 782,11

549 54933 224670401SOMATULINE AUTO GEL INJ.SOL 1 PF SYRx90MG

136 IPSEN EΠE N 930,67 809,68 829,92 1042,96

550 53215 224670101SOMATULINE PS.INJ.SUS. 1VIALx30MG (40MG)+1AMPx2ML SOLV+1ΣΥΡ+2ΒΕΛ.

136 IPSEN EΠE N 393,84 342,64 351,21 441,37

551 54957 253930302SOMAVERT PD.INJ.SO 1VIALx20MG+SOLV 8ML

295 PFIZER HELLAS ΑΕ N 143,17 124,56 127,67 160,44

552 54815 253930101SOMAVERT PD.INJ.SO BT 30VIALSx10MG+30VIALSx8ML SOLV

295 PFIZER HELLAS ΑΕ N 2080,78 1810,28 1855,54 2331,86

553 54816 253930201SOMAVERT PD.INJ.SO BT 30VIALSx15MG+30VIALSx8ML SOLV

295 PFIZER HELLAS ΑΕ N 3140,33 2732,09 2800,39 3519,25

554 54817 253930301SOMAVERT PD.INJ.SO BT 30VIALSx20MG+30VIALSx8ML SOLV

295 PFIZER HELLAS ΑΕ N 4161,55 3620,55 3711,06 4663,69

555 55652 275590103 SPRYCEL F.C. TABS 60x20MG (BLISTER) 461BRISTOL MYERS PHARMA EEIG

N 1898,49 1651,69 1692,98 2127,57

Page 37 of 46

Page 38: Κ ΑΡΧΕΙΟΥ Α Κ ΕΟΦ ΟΝΟΜΑΣΙΑ Κ ΕΤ ΠΕΡΙΓΡΑΦΗ … · 62 57322 248400705 aranesp solution for injection 60mcg/0,3ml pf.syr./ btx4pf.syr with needle guard

Α/ΑΚΩ∆. ΑΡΧΕΙΟΥ

ΓΓΕ ΚΩ∆. ΕΟΦ ΟΝΟΜΑΣΙΑ ΚΩ∆. ΕΤ. ΠΕΡΙΓΡΑΦΗ ΕΤΑΙΡΕΙΑΣ Ν.3816 ΧΟΝ∆ΡΙΚΗ ΝΟΣΟΚΟΜΕΙΑΚΗ Ν.ΧΟΝ∆ΡΙΚΗ ΛΙΑΝΙΚΗ

556 55653 275590101 SPRYCEL F.C. TABS 60x20MG (BOTTLE) 461BRISTOL MYERS PHARMA EEIG

N 1898,49 1651,69 1692,98 2127,57

557 55654 275590203 SPRYCEL F.C. TABS 60x50MG (BLISTER) 461BRISTOL MYERS PHARMA EEIG

N 3569,91 3105,82 3183,47 4000,67

558 55655 275590201 SPRYCEL F.C. TABS 60x50MG (BOTTLE) 461BRISTOL MYERS PHARMA EEIG

N 3569,91 3105,82 3183,47 4000,67

559 55656 275590303 SPRYCEL F.C. TABS 60x70MG (BLISTER) 461BRISTOL MYERS PHARMA EEIG

N 3569,91 3105,82 3183,47 4000,67

560 55657 275590301 SPRYCEL F.C. TABS 60x70MG (BOTTLE) 461BRISTOL MYERS PHARMA EEIG

N 3569,91 3105,82 3183,47 4000,67

561 56541 287170101STELARA INJ.SOL 45MG(90MG/ML)/0,5ML VIAL BTx1VIALx0,5ML

550JANSSEN-CILAG INT/NAL NV

N 3112,79 2708,13 2775,83 3488,39

562 55399 265090103SUBCUVIA INJ.SOL. 160MG/ML BTx1VIALx10ML

462 BAXTER AG N 67,55 58,77 60,24 75,70

563 55400 265090101SUBCUVIA INJ.SOL. 160MG/ML BTx1VIALx5ML

462 BAXTER AG N 33,90 29,49 30,23 37,99

564 55401 265090102SUBCUVIA INJ.SOL. 160MG/ML BTx20VIALSx5ML

462 BAXTER AG N 675,54 587,72 602,41 757,05

565 55402 265090104SUBCUVIA INJ.SOL. 160MG/ML BTx20VIALx10ML

462 BAXTER AG N 1351,08 1175,44 1204,83 1514,11

566 55658 273590101SUTENT CAPS 12,5MG/CAP BOTTLEx30CAPS

470 PFIZER LTD, UK N 1167,08 1015,36 1040,74 1307,90

567 55659 273590201SUTENT CAPS 25MG/CAP BOTTLEx30CAPS

470 PFIZER LTD, UK N 2323,63 2021,56 2072,10 2604,01

568 55660 273590301SUTENT CAPS 50MG/CAP BOTTLEx30CAPS

470 PFIZER LTD, UK N 4667,52 4060,74 4162,26 5230,71

569 53889 243750201SYNAGIS PS.INJ.SOL 1FLx100MG+SOLV 1ML

512 ABBOTT LABOR. LTD N 838,84 729,79 748,03 940,05

570 55404 270010201 TARCEVA F.C. TABS BT 30x100MG 315 ROCHE EΛΛAΣ ΑΕ N 1584,00 1378,08 1412,53 1775,13

Page 38 of 46

Page 39: Κ ΑΡΧΕΙΟΥ Α Κ ΕΟΦ ΟΝΟΜΑΣΙΑ Κ ΕΤ ΠΕΡΙΓΡΑΦΗ … · 62 57322 248400705 aranesp solution for injection 60mcg/0,3ml pf.syr./ btx4pf.syr with needle guard

Α/ΑΚΩ∆. ΑΡΧΕΙΟΥ

ΓΓΕ ΚΩ∆. ΕΟΦ ΟΝΟΜΑΣΙΑ ΚΩ∆. ΕΤ. ΠΕΡΙΓΡΑΦΗ ΕΤΑΙΡΕΙΑΣ Ν.3816 ΧΟΝ∆ΡΙΚΗ ΝΟΣΟΚΟΜΕΙΑΚΗ Ν.ΧΟΝ∆ΡΙΚΗ ΛΙΑΝΙΚΗ

571 55405 270010301 TARCEVA F.C. TABS BT 30x150MG 315 ROCHE EΛΛAΣ ΑΕ N 1953,78 1699,79 1742,28 2189,52

572 55406 270010101 TARCEVA F.C. TABS BT 30x25MG 315 ROCHE EΛΛAΣ ΑΕ N 339,82 295,64 303,03 380,82

573 54554 252720101 TARGRETIN CAPS BT 100x75MG 350 GALENICA AE N 1047,26 911,12 933,90 1173,63

574 56026 281690103TASIGNA HARD.CAPS 200MG/TAB BTx112TABS σε BLISTERS (PVC/OPA/ALU)

517NOVARTIS EUROPHARM LTD

N 4210,00 3662,70 3754,27 4717,99

575 56027 210970405TAXOL CS. SOL. INF.(Concentrate) 6MG/ML BTx1 VIAL MULTIDOSE (300MG)x50ML

460BRISTOL-MYERS SQUIBB AE

N 692,99 602,90 617,97 776,60

576 55407 210970406TAXOL CS. SOL. INF.(Concentrate) 6MG/ML BTx1(VIALx25MLx150MG)

460BRISTOL-MYERS SQUIBB AE

N 372,92 324,44 332,55 417,92

577 52469 210970401TAXOL CS.SOL.INF (CONCENTRATE) 6MG/ML BTx1VIAL 30MG/5ML

460BRISTOL-MYERS SQUIBB AE

N 74,57 64,88 66,50 83,57

578 53232 210970403TAXOL CS.SOL.INF (CONCENTRATE) 6MG/ML BTx1VIAL MULTIDOSE 100MG/17ML

460BRISTOL-MYERS SQUIBB AE

N 239,68 208,52 213,73 268,59

579 42404 263680303TAXOPROL CS.SOL. INF 6MG/ML BTx1VIAL(300MG)X50ml(MULTIDOSE)

700NOVENDIA PHARMACEUTICALS ΕΠΕ

N 561,32 488,35 500,56 629,05

580 41642 263680302TAXOPROL CS.SOL.INF. BTx1VIAL(100MG)X16,7ML (MULTIDOSE)

700NOVENDIA PHARMACEUTICALS ΕΠΕ

N 215,71 187,67 192,36 241,74

581 41643 263680301TAXOPROL CS.SOL.INF. BTx1VIAL(30MG)X5ML (MONODOSE)

700NOVENDIA PHARMACEUTICALS ΕΠΕ

N 67,11 58,39 59,85 75,21

582 52597 224860201 TAXOTERE 80MG/2,0ML/1VIAL 316 AVENTIS PHARMA ΑΒΕE N 546,97 475,86 487,76 612,97

583 57707 224860301TAXOTERE CS SOL INF 20MG/1ML BTx1VIALx1ML

316 AVENTIS PHARMA S.A. N 140,82 122,51 125,57 157,80

584 57708 224860401TAXOTERE CS SOL INF 80MG/4ML BTx1VIALx4ML

316 AVENTIS PHARMA S.A. N 546,94 475,84 487,74 612,94

585 52596 224860101 TAXOTERE INJ CO INF 1VIALx20MG/0,5ML 316 AVENTIS PHARMA ΑΒΕE N 140,83 122,52 125,58 157,82

Page 39 of 46

Page 40: Κ ΑΡΧΕΙΟΥ Α Κ ΕΟΦ ΟΝΟΜΑΣΙΑ Κ ΕΤ ΠΕΡΙΓΡΑΦΗ … · 62 57322 248400705 aranesp solution for injection 60mcg/0,3ml pf.syr./ btx4pf.syr with needle guard

Α/ΑΚΩ∆. ΑΡΧΕΙΟΥ

ΓΓΕ ΚΩ∆. ΕΟΦ ΟΝΟΜΑΣΙΑ ΚΩ∆. ΕΤ. ΠΕΡΙΓΡΑΦΗ ΕΤΑΙΡΕΙΑΣ Ν.3816 ΧΟΝ∆ΡΙΚΗ ΝΟΣΟΚΟΜΕΙΑΚΗ Ν.ΧΟΝ∆ΡΙΚΗ ΛΙΑΝΙΚΗ

586 57709 224860501TAXOTERE, CS.SOL.INF. 160MG/8ML, BT X 1 VIAL

316 AVENTIS PHARMA N 1022,62 889,68 911,92 1146,01

587 57060 241140303TEMODAL CAP 100MG/CAP BTx 5 σε ατοµικούς φακελλίσκους

476 SP.EUROPE N 363,68 316,40 324,31 407,56

588 57061 241140503TEMODAL CAP 140MG/CAP BTx 5 σε ατοµικούς φακελλίσκους

476 SP.EUROPE N 535,16 465,59 477,23 599,73

589 57062 241140603TEMODAL CAP 180MG/CAP BTx 5 σε ατοµικούς φακελλίσκους

476 SP.EUROPE N 685,00 595,95 610,85 767,66

590 57063 241140203TEMODAL CAP 20MG/CAP BTx 5 σε ατοµικούς φακελλίσκους

476 SP.EUROPE N 73,32 63,79 65,38 82,16

591 57064 241140403TEMODAL CAP 250MG/CAP BTx 5 σε ατοµικούς φακελλίσκους

476 SP.EUROPE N 917,39 798,13 818,08 1028,08

592 57065 241140103TEMODAL CAP 5MG/CAP SACHET (PET/ALU/PET)x5

476 SP.EUROPE N 19,48 16,95 17,37 21,83

593 53571 241140202 TEMODAL CAPS 20x20MG 476 SP.EUROPE N 271,74 236,41 242,32 304,52

594 53572 241140102 TEMODAL CAPS 20x5MG 476 SP.EUROPE N 72,18 62,80 64,37 80,89

595 53573 241140301 TEMODAL CAPS 5x100MG 476 SP.EUROPE N 382,82 333,05 341,38 429,01

596 53574 241140201 TEMODAL CAPS 5x20MG 476 SP.EUROPE N 77,20 67,16 68,84 86,51

597 53575 241140401 TEMODAL CAPS 5x250MG 476 SP.EUROPE N 965,68 840,14 861,14 1082,19

598 53576 241140101 TEMODAL CAPS 5x5MG 476 SP.EUROPE N 20,51 17,84 18,29 22,99

599 55920 241140502TEMODAL HARD CAPS 140MG/CAP BOTTLEx20 CAPS

476 SP.EUROPE N 1982,93 1725,15 1768,28 2222,20

600 55921 241140501TEMODAL HARD CAPS 140MG/CAP BOTTLEx5 CAPS

476 SP.EUROPE N 563,33 490,10 502,35 631,30

Page 40 of 46

Page 41: Κ ΑΡΧΕΙΟΥ Α Κ ΕΟΦ ΟΝΟΜΑΣΙΑ Κ ΕΤ ΠΕΡΙΓΡΑΦΗ … · 62 57322 248400705 aranesp solution for injection 60mcg/0,3ml pf.syr./ btx4pf.syr with needle guard

Α/ΑΚΩ∆. ΑΡΧΕΙΟΥ

ΓΓΕ ΚΩ∆. ΕΟΦ ΟΝΟΜΑΣΙΑ ΚΩ∆. ΕΤ. ΠΕΡΙΓΡΑΦΗ ΕΤΑΙΡΕΙΑΣ Ν.3816 ΧΟΝ∆ΡΙΚΗ ΝΟΣΟΚΟΜΕΙΑΚΗ Ν.ΧΟΝ∆ΡΙΚΗ ΛΙΑΝΙΚΗ

601 55922 241140601TEMODAL HARD CAPS 180MG/CAP BOTTLEx5 CAPS

476 SP.EUROPE N 721,06 627,32 643,00 808,06

602 56589 241140701TEMODAL PD.SOL.INF 2,5MG/ML BTx1BOTTLE

476 SP.EUROPE N 303,51 264,05 270,65 340,13

603 57710 241140504TEMODAL, CAP 140MG/CAP, SACHET(PET/ALU/PET) x 20

476 SP EUROPE N 1982,93 1725,15 1768,28 2222,20

604 57711 241140204TEMODAL, CAP 20MG/CAP, SACHET(PET/ALU/PET) x 20

476 SP EUROPE N 271,74 236,41 242,32 304,52

605 57712 241140104TEMODAL, CAP 5MG/CAP, SACHET(PET/ALU/PET) x 20

476 SP EUROPE N 72,17 62,79 64,36 80,88

606 57713 294530302TEMOMEDAC CAPS 100MG/CAP BOTTLEx20

522 MEDAC GESELLSCHAFT N 1091,49 949,60 973,34 1223,20

607 57714 294530301TEMOMEDAC CAPS 100MG/CAP BOTTLEx5

522 MEDAC GESELLSCHAFT N 310,09 269,78 276,52 347,50

608 57715 294530402TEMOMEDAC CAPS 140MG/CAP BOTTLEx20

522 MEDAC GESELLSCHAFT N 1606,17 1397,37 1432,30 1799,97

609 57716 294530401TEMOMEDAC CAPS 140MG/CAP BOTTLEx5

522 MEDAC GESELLSCHAFT N 456,30 396,98 406,90 511,35

610 57717 294530502TEMOMEDAC CAPS 180MG/CAP BOTTLEx20

522 MEDAC GESELLSCHAFT N 2055,89 1788,62 1833,34 2303,96

611 57718 294530501TEMOMEDAC CAPS 180MG/CAP BOTTLEx5

522 MEDAC GESELLSCHAFT N 584,06 508,13 520,83 654,53

612 57719 294530202TEMOMEDAC CAPS 20MG/CAP BOTTLEx20

522 MEDAC GESELLSCHAFT N 220,11 191,50 196,29 246,68

613 57720 294530201 TEMOMEDAC CAPS 20MG/CAP BOTTLEx5 522 MEDAC GESELLSCHAFT N 62,53 54,40 55,76 70,07

614 57721 294530602TEMOMEDAC CAPS 250MG/CAP BOTTLEx20

522 MEDAC GESELLSCHAFT N 2753,34 2395,41 2455,30 3085,58

615 57722 294530601TEMOMEDAC CAPS 250MG/CAP BOTTLEx5

522 MEDAC GESELLSCHAFT N 782,21 680,52 697,53 876,59

Page 41 of 46

Page 42: Κ ΑΡΧΕΙΟΥ Α Κ ΕΟΦ ΟΝΟΜΑΣΙΑ Κ ΕΤ ΠΕΡΙΓΡΑΦΗ … · 62 57322 248400705 aranesp solution for injection 60mcg/0,3ml pf.syr./ btx4pf.syr with needle guard

Α/ΑΚΩ∆. ΑΡΧΕΙΟΥ

ΓΓΕ ΚΩ∆. ΕΟΦ ΟΝΟΜΑΣΙΑ ΚΩ∆. ΕΤ. ΠΕΡΙΓΡΑΦΗ ΕΤΑΙΡΕΙΑΣ Ν.3816 ΧΟΝ∆ΡΙΚΗ ΝΟΣΟΚΟΜΕΙΑΚΗ Ν.ΧΟΝ∆ΡΙΚΗ ΛΙΑΝΙΚΗ

616 57723 294530102 TEMOMEDAC CAPS 5MG/CAP BOTTLEx20 522 MEDAC GESELLSCHAFT N 62,53 54,40 55,76 70,07

617 57724 294530101 TEMOMEDAC CAPS 5MG/CAP BOTTLEx5 522 MEDAC GESELLSCHAFT N 16,60 14,44 14,80 18,60

618 57066 293830302TEMOZOLOMIDE TEVA 100 mg hard capsules, BT x 20

644 TEVA PHARMA B.V. N 1212,72 1055,07 1081,45 1359,06

619 57067 293830301TEMOZOLOMIDE TEVA 100 mg hard capsules, BT x 5

644 TEVA PHARMA B.V. N 344,53 299,74 307,23 386,10

620 57068 293830402TEMOZOLOMIDE TEVA 140 mg hard capsules, BT x 20

644 TEVA PHARMA B.V. N 1784,60 1552,60 1591,42 1999,94

621 57069 293830401TEMOZOLOMIDE TEVA 140 mg hard capsules, BT x 5

644 TEVA PHARMA B.V. N 506,99 441,08 452,11 568,17

622 57070 293830502TEMOZOLOMIDE TEVA 180 mg hard capsules, BT x 20

644 TEVA PHARMA B.V. N 2284,24 1987,29 2036,97 2559,86

623 57071 293830501TEMOZOLOMIDE TEVA 180 mg hard capsules, BT x 5

644 TEVA PHARMA B.V. N 648,94 564,58 578,69 727,24

624 57073 293830201TEMOZOLOMIDE TEVA 20 mg hard capsules, BT x 5

644 TEVA PHARMA B.V. N 69,47 60,44 61,95 77,85

625 57072 293830202TEMOZOLOMIDE TEVA 20mg hard capsules, BT x 20

644 TEVA PHARMA B.V. N 244,55 212,76 218,08 274,06

626 57074 293830602TEMOZOLOMIDE TEVA 250 mg hard capsules, BT x 20

644 TEVA PHARMA B.V. N 3059,18 2661,49 2728,03 3428,32

627 57075 293830601TEMOZOLOMIDE TEVA 250 mg hard capsules, BT x 5

644 TEVA PHARMA B.V. N 869,09 756,11 775,01 973,96

628 57076 293830102TEMOZOLOMIDE TEVA 5 mg hard capsules, BT x 20

644 TEVA PHARMA B.V. N 64,97 56,52 57,93 72,80

629 57077 293830101TEMOZOLOMIDE TEVA 5 mg hard capsules, BT x 5

644 TEVA PHARMA B.V. N 18,46 16,06 16,46 20,69

630 56704 285240106TEVAGRASTIM INJ.SO INF 30MIU (300MCG)/0,5ML PF BTx5PF SYR µε προστ. καλ. Βε

663 TEVA GMBH N 229,24 199,44 204,43 256,91

Page 42 of 46

Page 43: Κ ΑΡΧΕΙΟΥ Α Κ ΕΟΦ ΟΝΟΜΑΣΙΑ Κ ΕΤ ΠΕΡΙΓΡΑΦΗ … · 62 57322 248400705 aranesp solution for injection 60mcg/0,3ml pf.syr./ btx4pf.syr with needle guard

Α/ΑΚΩ∆. ΑΡΧΕΙΟΥ

ΓΓΕ ΚΩ∆. ΕΟΦ ΟΝΟΜΑΣΙΑ ΚΩ∆. ΕΤ. ΠΕΡΙΓΡΑΦΗ ΕΤΑΙΡΕΙΑΣ Ν.3816 ΧΟΝ∆ΡΙΚΗ ΝΟΣΟΚΟΜΕΙΑΚΗ Ν.ΧΟΝ∆ΡΙΚΗ ΛΙΑΝΙΚΗ

631 56705 285240206TEVAGRASTIM INJ.SO INF 48MIU (480MCG)/0,8ML PF BTx5PF SYR µε προστ. καλ. Βε

663 TEVA GMBH N 360,72 313,83 321,68 404,26

632 56436 285240102TEVAGRASTIM INJ.SO.INF 30MIU (300MCG)/0,5ML BTx5PF.SYR

663 TEVA GMBH N 232,29 202,09 207,14 260,31

633 56437 285240202TEVAGRASTIM INJ.SO.INF 48MIU (480MCG)/0,8ML BTx5PF.SYR

663 TEVA GMBH N 365,53 318,01 325,96 409,63

634 56330 285210101THALIDOMIDE/CELGENE HARD CAPS 50MG/CAP BTx28 BLISTERS(PVC/PE/ACLAR/α

567 CELGENE EUROPE LTD N 396,43 344,89 353,51 444,26

635 55840 275580102THELIN F.C. TAB 100MG/TAB BTx28 BLISTERS (PVC/PE/PVDC/ALU)

295 PFIZER HELLAS ΑΕ N 2414,51 2100,62 2153,14 2705,85

636 54203 248950101 TOBI INH.SOL.N. BT 56AMPSx300MG/5ML 321 NOVARTIS HELLAS AEΒΕ N 2232,34 1942,14 1990,69 2501,70

637 57746 295070102TOPOTECAN HOSPIRA, C/S.SOL.IN 4MG/4ML, 5 VIALS x 4ML

654 HOSPIRA UK LTD N 757,64 659,15 675,63 849,06

638 57086 292230202TOPOTECAN/TEVA Πυκνό διάλυµα για παρασκευή διαλύµατος προς έγχυση 4 mg/4 ml BT x 5 vials x 4 ml

644 TEVA PHARMA B.V. N 1189,82 1035,14 1061,02 1333,38

639 56030 281290101TORISEL C.DI.S.INF 25MG/ML BTx1VIAL +1VIAL

295 PFIZER HELLAS ΑΕ N 969,55 843,51 864,60 1086,54

640 54675 252130201 TRACLEER F.C.TAB BT 56x125MG 020 ACTELION N 2681,07 2332,53 2390,84 3004,57

641 54676 252130102 TRACLEER F.C.TAB BT 56x62,5MG 020 ACTELION N 2681,07 2332,53 2390,84 3004,57

642 55411 252100101TRISENOX CS.SOL.INF 1MG/ML BTx10AMPSx10ML

142 CEPHALON UK LTD N 3970,00 3453,90 3540,25 4449,03

643 55663 273420101TYSABRI CS. SOL.INF 300MG/15ML VIAL BTx1VIALx15ML

097 ELAN N 1570,10 1365,99 1400,14 1759,56

644 56207 283710101TYVERB FC. TAB 250MG/TAB BTx70 σε BLISTERS (PA/ALU/PVC/ALU)

491GLAXO GROUP LTD, ENGLAND

N 1043,34 907,71 930,40 1169,23

645 56032 281500101VECTIBIX CS.SOL.INF 100MG/5ML VIAL (20MG/ML) BTx1VIALx5ML

023 AMGEN EUROPE B.V. N 415,57 361,55 370,59 465,72

Page 43 of 46

Page 44: Κ ΑΡΧΕΙΟΥ Α Κ ΕΟΦ ΟΝΟΜΑΣΙΑ Κ ΕΤ ΠΕΡΙΓΡΑΦΗ … · 62 57322 248400705 aranesp solution for injection 60mcg/0,3ml pf.syr./ btx4pf.syr with needle guard

Α/ΑΚΩ∆. ΑΡΧΕΙΟΥ

ΓΓΕ ΚΩ∆. ΕΟΦ ΟΝΟΜΑΣΙΑ ΚΩ∆. ΕΤ. ΠΕΡΙΓΡΑΦΗ ΕΤΑΙΡΕΙΑΣ Ν.3816 ΧΟΝ∆ΡΙΚΗ ΝΟΣΟΚΟΜΕΙΑΚΗ Ν.ΧΟΝ∆ΡΙΚΗ ΛΙΑΝΙΚΗ

646 56285 281500301VECTIBIX CS.SOL.INF 400MG/20ML VIAL (20MG/ML) BTx1VIALx20ML

023 AMGEN EUROPE B.V. N 1655,90 1440,63 1476,65 1855,71

647 55074 265480101 VELCADE PS.INJ.SOL 1VIALx3,5MG 061 JANSSEN-CILAG ΑΕΒΕ N 1038,11 903,16 925,74 1163,38

648 56639 281910101VENBIG PS.SOL.INF 50IU/ML BTx1VIALx500 IU+1 VIALx10ML SOLV+ σετ έγχ

540KEDRION SPA LUCCA ITALY

N 346,06 301,07 308,60 387,82

649 55075 256250102 VENTAVIS INH.SOL AMP 100x20MCG/2ML 569BAYER SHERING PHARMA AG

N 2366,34 2058,72 2110,19 2651,88

650 56286 256250106 VENTAVIS INH.SOL BTx90AMPSx2ML 569BAYER SHERING PHARMA AG

N 2154,43 1874,35 1921,21 2414,38

651 56548 287110101 VIDAZA PD.INJ.SUS 25MG/ML BTx 1 VIAL 567 CELGENE EUROPE LTD N 372,90 324,42 332,53 417,89

652 55842 272160101VINORELBIN/EBEWE C/S SOL IN 10MG/ML BTx1VIALx1ML

564 EBEWE PHARMA GMBH N 16,28 14,16 14,51 18,23

653 55843 272160102VINORELBIN/EBEWE C/S SOL IN 10MG/ML BTx1VIALx5ML

564 EBEWE PHARMA GMBH N 76,90 66,90 68,57 86,17

654 42405 286340103VINTECAN CS.SOL.INF 20MG/ML BTx1 (VIALx15ML)AMBEM GLASS

589AURORA PHARMACEUTICALS AE

N 348,74 303,40 310,99 390,82

655 42406 286340101VINTECAN CS.SOL.INF 20MG/ML BTx1 (VIALx2ML)AMBEM GLASS

589AURORA PHARMACEUTICALS AE

N 46,51 40,46 41,47 52,12

656 42407 286340102VINTECAN CS.SOL.INF 20MG/ML BTx1 (VIALx5ML)AMBEM GLASS

589AURORA PHARMACEUTICALS AE

N 116,25 101,14 103,67 130,28

657 54678 253400101 VIREAD F.C.TABL FL 30x245MG 068 GILEAD N 297,30 258,65 265,12 333,18

658 54084 246890101 VISUDINE PS SO INF 1 VIAL X15MG/10ML 321 NOVARTIS HELLAS AEΒΕ N 1098,66 955,83 979,73 1231,23

659 55601 265920102 VIVAGLOBIN INJ.SOL.16% BTx10AMPx5ML 438 CSL BEHRING Μ.ΕΠΕ N 305,24 265,56 272,20 342,07

660 55602 265920104VIVAGLOBIN INJ.SOL.16% BTx10VIALSx10ML

438 CSL BEHRING Μ.ΕΠΕ N 589,07 512,49 525,30 660,14

Page 44 of 46

Page 45: Κ ΑΡΧΕΙΟΥ Α Κ ΕΟΦ ΟΝΟΜΑΣΙΑ Κ ΕΤ ΠΕΡΙΓΡΑΦΗ … · 62 57322 248400705 aranesp solution for injection 60mcg/0,3ml pf.syr./ btx4pf.syr with needle guard

Α/ΑΚΩ∆. ΑΡΧΕΙΟΥ

ΓΓΕ ΚΩ∆. ΕΟΦ ΟΝΟΜΑΣΙΑ ΚΩ∆. ΕΤ. ΠΕΡΙΓΡΑΦΗ ΕΤΑΙΡΕΙΑΣ Ν.3816 ΧΟΝ∆ΡΙΚΗ ΝΟΣΟΚΟΜΕΙΑΚΗ Ν.ΧΟΝ∆ΡΙΚΗ ΛΙΑΝΙΚΗ

661 55603 265920101 VIVAGLOBIN INJ.SOL.16% BTx1AMPx5ML 438 CSL BEHRING Μ.ΕΠΕ N 30,52 26,55 27,21 34,19

662 55604 265920103 VIVAGLOBIN INJ.SOL.16% BTx1VIALx10ML 438 CSL BEHRING Μ.ΕΠΕ N 58,91 51,25 52,53 66,01

663 55605 265920105VIVAGLOBIN INJ.SOL.16% BTx20VIALSx10ML

438 CSL BEHRING Μ.ΕΠΕ N 1180,62 1027,14 1052,82 1323,08

664 56208 283630202VOLIBRIS F.C.TAB 10MG/TAB BTx30 σε BLIST (PVC/PVDC/ALU)

491GLAXO GROUP LTD, ENGLAND

N 3025,40 2632,10 2697,90 3390,45

665 56209 283630102VOLIBRIS F.C.TAB 5MG/TAB BTx30 σε BLIST (PVC/PVDC/ALU)

491GLAXO GROUP LTD, ENGLAND

N 3025,40 2632,10 2697,90 3390,45

666 57302 295000102VOTRIENT FC.TAB 200MG/TAB 1 BOTTLE (HDPE) x 90

411 GLAXOSMITHKLINE AEBE N 2008,11 1747,06 1790,74 2250,42

667 57303 295000202VOTRIENT FC.TAB 400MG/TAB 1 BOTTLE (HDPE) x 60

411 GLAXOSMITHKLINE AEBE N 2802,80 2438,44 2499,40 3141,00

668 55448 267360101XAGRID 0.5MG (HARD CAPS) BOTTLEx100 CAPS

490SHIRE PHAR/CAL CONTR.LTD

N 420,87 366,16 375,31 471,65

669 54215 247120201 XELODA F.C.TAB. BT 120x500MG 315 ROCHE EΛΛAΣ ΑΕ N 328,07 285,42 292,56 367,66

670 54216 247120101 XELODA F.C.TAB. BT 60x150MG 315 ROCHE EΛΛAΣ ΑΕ N 47,10 40,98 42,00 52,78

671 56590 287850103XENIUS CS.SOL.INF 6MG/1ML BTx1VIALx17ML

686 ALAPIS ABEE N 215,70 187,66 192,35 241,73

672 56521 287850102XENIUS CS.SOL.INF 6MG/1ML BTx1VIALx25ML

686 ALAPIS ABEE N 335,62 291,99 299,29 376,12

673 56591 287850104XENIUS CS.SOL.INF 6MG/1ML BTx1VIALx50ML

686 ALAPIS ABEE N 623,68 542,60 556,17 698,94

674 56522 287850101XENIUS CS.SOL.INF 6MG/1ML BTx1VIALx5ML

686 ALAPIS ABEE N 67,11 58,39 59,85 75,21

675 57304 249920401XOLAIR INJ.SOL 150MG/1,0ML BTx1PF.SYRx1,0ML

517NOVARTIS EUROPHARM LTD

N 351,56 305,86 313,51 393,99

Page 45 of 46

Page 46: Κ ΑΡΧΕΙΟΥ Α Κ ΕΟΦ ΟΝΟΜΑΣΙΑ Κ ΕΤ ΠΕΡΙΓΡΑΦΗ … · 62 57322 248400705 aranesp solution for injection 60mcg/0,3ml pf.syr./ btx4pf.syr with needle guard

Α/ΑΚΩ∆. ΑΡΧΕΙΟΥ

ΓΓΕ ΚΩ∆. ΕΟΦ ΟΝΟΜΑΣΙΑ ΚΩ∆. ΕΤ. ΠΕΡΙΓΡΑΦΗ ΕΤΑΙΡΕΙΑΣ Ν.3816 ΧΟΝ∆ΡΙΚΗ ΝΟΣΟΚΟΜΕΙΑΚΗ Ν.ΧΟΝ∆ΡΙΚΗ ΛΙΑΝΙΚΗ

676 57109 249920301XOLAIR INJ.SOL. 75MG/0,5ML PF SYR / BTx1 PF SYR x 0.5ML

517NOVARTIS EUROPHARM LTD

N 190,25 165,52 169,66 213,21

677 55451 249920201XOLAIR PS.INJ.SOL. 150MG/VIAL BTx1VIAL + 1AMP + 2ML/SOLV

517NOVARTIS EUROPHARM LTD

N 351,56 305,86 313,51 393,99

678 56041 281300101YONDELIS PD.C.SOL.INF. 0,25MG/VIAL BTx1 VIAL

603 PHARMA MAR, S.A. N 550,06 478,55 490,51 616,42

679 56042 281300201YONDELIS PD.C.SOL.INF. 1MG/VIAL BTx1 VIAL

603 PHARMA MAR, S.A. N 2069,71 1800,65 1845,67 2319,45

680 57110 287970103ZARZIO SO.INJ.INF. 30MU(60MU/ML) 0,5 ML PF SYR BTx5PF. SYR

339 SANDOZ GMBH AUSTRIA N 231,31 201,24 206,27 259,22

681 57111 287970203ZARZIO SO.INJ.INF. 48MU(96MU/ML) 0,5 ML PF SYR BTx5PF. SYR

339 SANDOZ GMBH AUSTRIA N 340,00 295,80 303,20 381,03

682 54902 260250101 ZAVESCA HARD CAPS BT 84x100MG 020 ACTELION N 7040,20 6124,97 6278,09 7889,68

683 54395 248150201 ZOMETA CS.SOL.INF 1VIALX4MG/5ML 321 NOVARTIS HELLAS AEΒΕ N 237,38 206,52 211,68 266,02

Page 46 of 46